Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
19 "Mitochondria"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Review Article
Diabetes, obesity and metabolism
The Emerging Importance of Mitochondria in White Adipocytes: Neither Last nor Least
Juan Cai, Fenfen Wang, Mengle Shao
Endocrinol Metab. 2023;38(5):493-503.   Published online October 10, 2023
DOI: https://doi.org/10.3803/EnM.2023.1813
  • 1,926 View
  • 92 Download
AbstractAbstract PDFPubReader   ePub   
The growing recognition of mitochondria’s crucial role in the regulation of white adipose tissue remodeling and energy balance underscores its significance. The marked metabolic diversity of mitochondria provides the molecular and cellular foundation for enabling adipose tissue plasticity in response to various metabolic cues. Effective control of mitochondrial function at the cellular level, not only in thermogenic brown and beige adipocytes but also in energy-storing white adipocytes, exerts a profound influence on adipose homeostasis. Furthermore, mitochondria play a pivotal role in intercellular communication within adipose tissue via production of metabolites with signaling properties. A more comprehensive understanding of mitochondrial regulation within white adipocytes will empower the development of targeted and efficacious strategies to enhance adipose function, leading to advancements in overall metabolic health.
Close layer
Original Articles
Diabetes, Obesity and Metabolism
Gemigliptin Alleviates Succinate-Induced Hepatic Stellate Cell Activation by Ameliorating Mitochondrial Dysfunction
Giang Nguyen, So Young Park, Dinh Vinh Do, Dae-Hee Choi, Eun-Hee Cho
Endocrinol Metab. 2022;37(6):918-928.   Published online November 15, 2022
DOI: https://doi.org/10.3803/EnM.2022.1530
  • 3,450 View
  • 229 Download
  • 2 Web of Science
  • 3 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
Dipeptidyl peptidase-4 inhibitors (DPP-4Is) are used clinically as oral antidiabetic agents. Although DPP-4Is are known to ameliorate liver fibrosis, the protective mechanism of DPP-4Is in liver fibrosis remains obscure. In this study, gemigliptin was used to investigate the potential of DPP-4Is to alleviate the progression of liver fibrosis.
Methods
To clarify the effects and mechanisms of gemigliptin, we conducted various experiments in LX-2 cells (immortalized human hepatic stellate cells [HSCs], the principal effectors of hepatic fibrogenesis), which were activated by succinate and exhibited elevated expression of α-smooth muscle actin, collagen type 1, and pro-inflammatory cytokines and increased cell proliferation. In vivo, we examined the effects and mechanisms of gemigliptin on a high-fat, high-cholesterol–induced mouse model of nonalcoholic steatohepatitis (NASH).
Results
Gemigliptin decreased the expression of fibrogenesis markers and reduced the abnormal proliferation of HSCs. In addition, gemigliptin reduced the succinate-induced production of mitochondrial reactive oxygen species (ROS), intracellular ROS, and mitochondrial fission in HSCs. Furthermore, in the mouse model of NASH-induced liver fibrosis, gemigliptin alleviated both liver fibrosis and mitochondrial dysfunction.
Conclusion
Gemigliptin protected against HSC activation and liver fibrosis by alleviating mitochondrial dysfunction and ROS production, indicating its potential as a strategy for preventing the development of liver disease.

Citations

Citations to this article as recorded by  
  • Improvement effect of gemigliptin on salivary gland dysfunction in exogenous methylglyoxal-injected rats
    Woo Kwon Jung, Su-Bin Park, Hwa Young Yu, Junghyun Kim
    Heliyon.2024; 10(8): e29362.     CrossRef
  • Gemigliptin, a DPP4 inhibitor, ameliorates nonalcoholic steatohepatitis through AMP-activated protein kinase-independent and ULK1-mediated autophagy
    Youngmi Song, Hyekyung Yang, Juhee Kim, Yoonjin Lee, Sung-Ho Kim, In-Gu Do, Cheol-Young Park
    Molecular Metabolism.2023; 78: 101806.     CrossRef
  • DPP-4 Inhibitor in Type 2 Diabetes Mellitus Patient with Non-Alcoholic Fatty Liver Disease: Achieving Two Goals at Once?
    Ji Cheol Bae
    Endocrinology and Metabolism.2022; 37(6): 858.     CrossRef
Close layer
Miscellaneous
Clinical Value of Serum Mitochondria-Inhibiting Substances in Assessing Renal Hazards: A Community-Based Prospective Study in Korea
Hoon Sung Choi, Jin Taek Kim, Hong Kyu Lee, Wook Ha Park, Youngmi Kim Pak, Sung Woo Lee
Endocrinol Metab. 2021;36(6):1298-1306.   Published online November 26, 2021
DOI: https://doi.org/10.3803/EnM.2021.1226
  • 3,254 View
  • 95 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
Mitochondrial dysfunction is strongly associated with several kidney diseases. However, no studies have evaluated the potential renal hazards of serum mitochondria-inhibiting substance (MIS) and aryl hydrocarbon receptor ligand (AhRL) levels.
Methods
We used serum level of MIS and AhRL and clinical renal outcomes from 1,511 participants of a prospective community-based cohort in Ansung. MIS was evaluated based on intracellular adenosine triphosphate (MIS-ATP) or reactive oxygen species (MIS-ROS) generation measured using cell-based assays.
Results
During a mean 6.9-year follow-up, 84 participants (5.6%) developed a rapid decline in kidney function. In the lowest quartile group of MIS-ATP, patients were older and had metabolically deleterious parameters. In multivariate logistic regression analysis, higher MIS-ATP was associated with decreased odds for rapid decline: the odds ratio (OR) of 1% increase was 0.977 (95% confidence interval [CI], 0.957 to 0.998; P=0.031), while higher MIS-ROS was marginally associated with increased odds for rapid decline (OR, 1.014; 95% CI, 0.999 to 1.028; P=0.055). However, serum AhRL was not associated with the rapid decline in kidney function. In subgroup analysis, the renal hazard of MIS was particularly evident in people with hypertension and low baseline kidney function.
Conclusion
Serum MIS was independently associated with a rapid decline in kidney function, while serum AhRL was not. The clinical implication of renal hazard on serum MIS requires further evaluation in future studies.

Citations

Citations to this article as recorded by  
  • An Interactive Online App for Predicting Diabetes via Machine Learning from Environment-Polluting Chemical Exposure Data
    Rosy Oh, Hong Kyu Lee, Youngmi Kim Pak, Man-Suk Oh
    International Journal of Environmental Research and Public Health.2022; 19(10): 5800.     CrossRef
Close layer
Namgok Lecture 2020
Obesity and Metabolism
Cellular and Intercellular Homeostasis in Adipose Tissue with Mitochondria-Specific Stress
Min Jeong Choi, Saet-Byel Jung, Joon Young Chang, Minho Shong
Endocrinol Metab. 2021;36(1):1-11.   Published online February 24, 2021
DOI: https://doi.org/10.3803/EnM.2021.956
  • 5,458 View
  • 227 Download
  • 2 Web of Science
  • 2 Crossref
AbstractAbstract PDFPubReader   ePub   
Paracrine interactions are imperative for the maintenance of adipose tissue intercellular homeostasis, and intracellular organelle dysfunction results in local and systemic alterations in metabolic homeostasis. It is currently accepted that mitochondrial proteotoxic stress activates the mitochondrial unfolded protein response (UPRmt) in vitro and in vivo. The induction of mitochondrial chaperones and proteases during the UPRmt is a key cell-autonomous mechanism of mitochondrial quality control. The UPRmt also affects systemic metabolism through the secretion of cell non-autonomous peptides and cytokines (hereafter, metabokines). Mitochondrial function in adipose tissue plays a pivotal role in whole-body metabolism and human diseases. Despite continuing interest in the role of the UPRmt and quality control pathways of mitochondria in energy metabolism, studies on the roles of the UPRmt and metabokines in white adipose tissue are relatively sparse. Here, we describe the role of the UPRmt in adipose tissue, including adipocytes and resident macrophages, and the interactive roles of cell non-autonomous metabokines, particularly growth differentiation factor 15, in local adipose cellular homeostasis and systemic energy metabolism.

Citations

Citations to this article as recorded by  
  • Mitochondrial stress-induced GFRAL signaling controls diurnal food intake and anxiety-like behavior
    Carla Igual Gil, Bethany M Coull, Wenke Jonas, Rachel N Lippert, Susanne Klaus, Mario Ost
    Life Science Alliance.2022; 5(11): e202201495.     CrossRef
  • Stress-induced FGF21 and GDF15 in obesity and obesity resistance
    Susanne Keipert, Mario Ost
    Trends in Endocrinology & Metabolism.2021; 32(11): 904.     CrossRef
Close layer
Review Articles
Miscellaneous
Sarcopenia and Muscle Aging: A Brief Overview
Tam Dao, Alexander E. Green, Yun A Kim, Sung-Jin Bae, Ki-Tae Ha, Karim Gariani, Mi-ra Lee, Keir J. Menzies, Dongryeol Ryu
Endocrinol Metab. 2020;35(4):716-732.   Published online December 23, 2020
DOI: https://doi.org/10.3803/EnM.2020.405
  • 22,717 View
  • 1,264 Download
  • 74 Web of Science
  • 79 Crossref
AbstractAbstract PDFPubReader   ePub   
The world is facing the new challenges of an aging population, and understanding the process of aging has therefore become one of the most important global concerns. Sarcopenia is a condition which is defined by the gradual loss of skeletal muscle mass and function with age. In research and clinical practice, sarcopenia is recognized as a component of geriatric disease and is a current target for drug development. In this review we define this condition and provide an overview of current therapeutic approaches. We further highlight recent findings that describe key pathophysiological phenotypes of this condition, including alterations in muscle fiber types, mitochondrial function, nicotinamide adenine dinucleotide (NAD+) metabolism, myokines, and gut microbiota, in aged muscle compared to young muscle or healthy aged muscle. The last part of this review examines new therapeutic avenues for promising treatment targets. There is still no accepted therapy for sarcopenia in humans. Here we provide a brief review of the current state of research derived from various mouse models or human samples that provide novel routes for the development of effective therapeutics to maintain muscle health during aging.

Citations

Citations to this article as recorded by  
  • Interactions between mitochondrial dysfunction and other hallmarks of aging: Paving a path toward interventions that promote healthy old age
    Yuan Li, Laura Berliocchi, Zhiquan Li, Lene Juel Rasmussen
    Aging Cell.2024;[Epub]     CrossRef
  • Circulating lumican as a potential biomarker for osteosarcopenia in older adults
    So Jeong Park, Eunhye Ji, Hyun Ju Yoo, Kyunggon Kim, Sunghwan Ji, Ji Yeon Baek, Jin Young Lee, Hee-Won Jung, Il-Young Jang, Eunju Lee, Namki Hong, Beom-Jun Kim
    Bone.2024; 179: 116959.     CrossRef
  • D‐galactose might mediate some of the skeletal muscle hypertrophy‐promoting effects of milk—A nutrient to consider for sarcopenia?
    Jan Homolak, Ana Babic Perhoc, Davor Virag, Ana Knezovic, Jelena Osmanovic Barilar, Melita Salkovic‐Petrisic
    BioEssays.2024;[Epub]     CrossRef
  • Dark tea extract attenuates age-related muscle loss by suppressing oxidative stress and inflammation in skeletal muscle of mice
    Ahyoung Yoo, Hyo Deok Seo, Jeong-Hoon Hahm, Chang Hwa Jung, Jiyun Ahn, Tae Youl Ha
    Journal of Functional Foods.2024; 112: 105980.     CrossRef
  • Moderate dietary restriction delays the onset of age-associated sarcopenia in Caenorhabditis elegans due to reduced myosin UNC-54 degradation
    Sobha Tumbapo, Adam Strudwick, Jana J. Stastna, Simon C. Harvey, Marieke J. Bloemink
    Mechanisms of Ageing and Development.2024; 217: 111900.     CrossRef
  • Trop T, hand grip strength and waist circumference as markers of sarcopenic obesity in postmenopausal women: An analytical cross-sectional study
    Sheetal Sarangi, Arul Senghor K. A., Vinodhini V. M.
    Indian Journal of Physiology and Pharmacology.2024; 68: 57.     CrossRef
  • Temporal Muscle Thickness: A Practical Approximation for Assessing Muscle Mass in Older Adults
    Miguel German Borda, Jonathan Patricio Baldera, Jessica Samuelsson, Anna Zettergren, Lina Rydén, Eric Westman, Mario Ulises Pérez-Zepeda, Silke Kern, Luis Carlos Venegas, Gustavo Duque, Ingmar Skoog, Dag Aarsland
    Journal of the American Medical Directors Association.2024; 25(4): 664.     CrossRef
  • Undernutrition in obese older adults by fat percentage
    Meris Esra Bozkurt, Tugba Erdogan, Nezahat Muge Catikkas, Serdar Ozkok, Cihan Kilic, Gulistan Bahat, Mehmet Akif Karan
    Aging Clinical and Experimental Research.2024;[Epub]     CrossRef
  • The BET inhibitor JQ1 targets fat metabolism and counteracts obesity
    Claudia Fornelli, Alessia Sofia Cento, Lorenzo Nevi, Raffaella Mastrocola, Gustavo Ferreira Alves, Giuseppina Caretti, Massimo Collino, Fabio Penna
    Journal of Advanced Research.2024;[Epub]     CrossRef
  • Effects of Low-Load Blood Flow Restriction Training on Muscle Anabolism Biomarkers and Thrombotic Biomarkers Compared with Traditional Training in Healthy Adults Older Than 60 Years: Systematic Review and Meta-Analysis
    Raúl Fabero-Garrido, Miguel Gragera-Vela, Tamara del Corral, Marta Hernández-Martín, Gustavo Plaza-Manzano, Ibai López-de-Uralde-Villanueva
    Life.2024; 14(3): 411.     CrossRef
  • Sarcopenia and non-alcoholic fatty liver disease
    R. G. Myazin
    Experimental and Clinical Gastroenterology.2024; (2): 120.     CrossRef
  • THE ROLE OF DAIRY FOODS FOR HEALTHY AGING
    Emine Kocyigit
    Anti-Aging Eastern Europe.2024; 3(1): 23.     CrossRef
  • Effects of Rosemary Extract on C2C12 Myoblast Differentiation and 5-Aminoimidazole-4-carboxamide Ribonucleoside (AICAR)-Induced Muscle Cell Atrophy
    Jun Ho Lee, Jung Yoon Jang, Young Hoon Kwon, Seung Ho Lee, Cheol Park, Yung Hyun Choi, Nam Deuk Kim
    Applied Sciences.2023; 13(2): 986.     CrossRef
  • Relationship between asthma and sarcopenia in the elderly: a nationwide study from the KNHANES
    Ha-Kyeong Won, Yewon Kang, Jin An, Ji-Hyang Lee, Woo-Jung Song, Hyouk-Soo Kwon, You Sook Cho, Hee-Bom Moon, Il-Young Jang, Tae-Bum Kim
    Journal of Asthma.2023; 60(2): 304.     CrossRef
  • A Lignan from Alnus japonica Activates Myogenesis and Alleviates Dexamethasone-induced Myotube Atrophy
    Hyejin Lee, Ji Hye Jeong, Seung Hwan Hwang, Sung Hum Yeon, Jae-Ha Ryu
    Planta Medica.2023; 89(05): 484.     CrossRef
  • A cross-talk between sestrins, chronic inflammation and cellular senescence governs the development of age-associated sarcopenia and obesity
    Gregory Livshits, Alexander Kalinkovich
    Ageing Research Reviews.2023; 86: 101852.     CrossRef
  • Facilitators and Barriers of Tai Chi Practice in Community-Dwelling Older Adults: Qualitative Study
    Yan Du, Penny Roberts, Wei Liu
    Asian/Pacific Island Nursing Journal.2023; 7: e42195.     CrossRef
  • Extract of Alnus japonica prevents dexamethasone-induced muscle atrophy in mice
    Hyejin Lee, Kyeong Seon Lee, Ji Hye Jeong, Ji Soo Yoon, Seung Hwan Hwang, Sang-Yoon Kim, Sung Hum Yeon, Jae-Ha Ryu
    Journal of Functional Foods.2023; 101: 105419.     CrossRef
  • Axis “microbiota - muscle”
    A. N. Zavyalova, V. P. Novikova, P. D. Ignatova
    Experimental and Clinical Gastroenterology.2023; (11): 60.     CrossRef
  • Comparison of the effects of commercial whey protein and native whey protein on muscle strength and muscle protein synthesis in rats
    Jiyun Kim, Eun Woo Jeong, Youjin Baek, Gwang-woong Go, Hyeon Gyu Lee
    Food Science and Biotechnology.2023; 32(3): 381.     CrossRef
  • Prevalence of sarcopenia in patients with COPD through different musculature measurements: An updated meta-analysis and meta-regression
    Jie He, Hezhi Li, Jun Yao, Yan Wang
    Frontiers in Nutrition.2023;[Epub]     CrossRef
  • Proteome network analysis of skeletal muscle in lignan-enriched nutmeg extract-fed aged mice
    Je-Ho Lee, Hyuno Kang, Gyung-Tae Ban, Beom Kyu Kim, JaeHyeon Lee, Heeyoun Hwang, Hwa-Seung Yoo, Kun Cho, Jong-Soon Choi
    Journal of Analytical Science and Technology.2023;[Epub]     CrossRef
  • Aging, Physical Exercise, Telomeres, and Sarcopenia: A Narrative Review
    David Hernández-Álvarez, Juana Rosado-Pérez, Graciela Gavia-García, Taide Laurita Arista-Ugalde, Itzen Aguiñiga-Sánchez, Edelmiro Santiago-Osorio, Víctor Manuel Mendoza-Núñez
    Biomedicines.2023; 11(2): 598.     CrossRef
  • Genetic and Probiotic Characteristics of Urolithin A Producing Enterococcus faecium FUA027
    Mengjie Xia, Shuting Mu, Yaowei Fang, Xiaomeng Zhang, Guang Yang, Xiaoyue Hou, Fuxiang He, Yaling Zhao, Yichen Huang, Wei Zhang, Juan Shen, Shu Liu
    Foods.2023; 12(5): 1021.     CrossRef
  • A nomogram to predict the risk of sarcopenia in older people
    Guangjiao Yin, Juanjuan Qin, Ziwei Wang, Fang Lv, Xujun Ye
    Medicine.2023; 102(16): e33581.     CrossRef
  • Air pollution weaken your muscle? Evidence from a cross-sectional study on sarcopenia in central China
    Faxue Zhang, Tianzhou Li, Bingbing Chen, Nuoya Li, Xupeng Zhang, Shijie Zhu, Gaichan Zhao, Xiaowei Zhang, TingTing Ma, Fang Zhou, Hao Liu, Wei Zhu
    Ecotoxicology and Environmental Safety.2023; 258: 114962.     CrossRef
  • Safety and Risk Factors of Needle Thoracentesis Decompression in Tension Pneumothorax in Patients over 75 Years Old
    Yanhu Wang, Lei Wang, Cheng Chen, Yifan Que, Yinyi Li, Jiang Luo, Ming Yin, Miao Lv, Guogang Xu, Anita Pye
    Canadian Respiratory Journal.2023; 2023: 1.     CrossRef
  • Allosteric modulation of ryanodine receptor RyR1 by nucleotide derivatives
    Spencer Cholak, James W. Saville, Xing Zhu, Alison M. Berezuk, Katharine S. Tuttle, Omid Haji-Ghassemi, Francisco J. Alvarado, Filip Van Petegem, Sriram Subramaniam
    Structure.2023; 31(7): 790.     CrossRef
  • Sarcopenia and Cardiovascular Diseases
    Abdulla A. Damluji, Maha Alfaraidhy, Noora AlHajri, Namit N. Rohant, Manish Kumar, Christina Al Malouf, Samira Bahrainy, Min Ji Kwak, Wayne B. Batchelor, Daniel E. Forman, Michael W. Rich, James Kirkpatrick, Ashok Krishnaswami, Karen P. Alexander, Gary Ge
    Circulation.2023; 147(20): 1534.     CrossRef
  • Mitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging-Related Diseases
    Byung Soo Kong, Changhan Lee, Young Min Cho
    Diabetes & Metabolism Journal.2023; 47(3): 315.     CrossRef
  • Pathogenesis, Intervention, and Current Status of Drug Development for Sarcopenia: A Review
    Jung Yoon Jang, Donghwan Kim, Nam Deuk Kim
    Biomedicines.2023; 11(6): 1635.     CrossRef
  • Polyamines and Physical Activity in Musculoskeletal Diseases: A Potential Therapeutic Challenge
    Letizia Galasso, Annalisa Cappella, Antonino Mulè, Lucia Castelli, Andrea Ciorciari, Alessandra Stacchiotti, Angela Montaruli
    International Journal of Molecular Sciences.2023; 24(12): 9798.     CrossRef
  • Non-alcoholic fatty liver disease in women – Current knowledge and emerging concepts
    Pei Chia Eng, Roberta Forlano, Tricia Tan, Pinelopi Manousou, Waljit S. Dhillo, Chioma Izzi-Engbeaya
    JHEP Reports.2023; 5(10): 100835.     CrossRef
  • Effects of polyphenols and their metabolites on age-related diseases
    Chouari Zhor, Lounis Wafaa, Imen Ghzaiel, Khadidja Kessas, Amira Zarrouk, Mohamed Ksila, Taoufik Ghrairi, Norbert Latruffe, Olfa Masmoudi-Kouki, Adil El Midaoui, Dominique Vervandier-Fasseur, Mohamed Hammami, Gérard Lizard, Anne Vejux, Omar Kharoubi
    Biochemical Pharmacology.2023; 214: 115674.     CrossRef
  • Circadian regulation in aging: Implications for spaceflight and life on earth
    Deeksha Malhan, Britt Schoenrock, Müge Yalçin, Dieter Blottner, Angela Relόgio
    Aging Cell.2023;[Epub]     CrossRef
  • Mitochondria-associated programmed cell death as a therapeutic target for age-related disease
    Thanh T. Nguyen, Shibo Wei, Thu Ha Nguyen, Yunju Jo, Yan Zhang, Wonyoung Park, Karim Gariani, Chang-Myung Oh, Hyeon Ho Kim, Ki-Tae Ha, Kyu Sang Park, Raekil Park, In-Kyu Lee, Minho Shong, Riekelt H. Houtkooper, Dongryeol Ryu
    Experimental & Molecular Medicine.2023; 55(8): 1595.     CrossRef
  • Normative reference values, determinants and regression equations for the incremental shuttle walk test (ISWT) in healthy Asian population aged 21 to 80 years
    Muhammad Zulhaziq Bin Azman, Katherin S. Huang, Wei Jun Koh, Sarah S. Leong, Benjamin Ong, Johanna L. Soon, Sherman W. Tan, Melissa Y. Chan, Mingxing Yang, Meredith T. Yeung, Hans-Peter Kubis
    PLOS ONE.2023; 18(9): e0291132.     CrossRef
  • Influence of sarcopenia on postoperative complications in patients undergoing autologous microsurgical breast reconstruction: an inverse probability of treatment weighting analysis
    Seung-Jun Lee, Yun-Jung Yang, Dong-Won Lee, Seung-Yong Song, Dae-Hyun Lew, Eun-Jung Yang
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Stromal vascular fraction in the treatment of myositis
    S. Gandolfi, B. Pileyre, L. Drouot, I. Dubus, I. Auquit-Auckbur, J. Martinet
    Cell Death Discovery.2023;[Epub]     CrossRef
  • Multidisciplinary approach to sarcopenia: a narrative review
    Wook Tae Park, Oog-Jin Shon, Gi Beom Kim
    Journal of Yeungnam Medical Science.2023; 40(4): 352.     CrossRef
  • Metallosis after Hip Arthroplasty Damages Skeletal Muscle: A Case Report
    Roberto Bonanni, Lorenzo Abbondante, Ida Cariati, Elena Gasbarra, Umberto Tarantino
    Geriatrics.2023; 8(5): 92.     CrossRef
  • Hallmarks of ageing in human skeletal muscle and implications for understanding the pathophysiology of sarcopenia in women and men
    Antoneta Granic, Karen Suetterlin, Tea Shavlakadze, Miranda D. Grounds, Avan A. Sayer
    Clinical Science.2023; 137(22): 1721.     CrossRef
  • Predicted lean body mass trajectories, and cancer risk and cancer‐specific and all‐cause mortality: A prospective cohort study
    Chenan Liu, Qingsong Zhang, Tong Liu, Qi Zhang, Mengmeng Song, Guotian Ruan, Shiqi Lin, Ziwen Wang, Xin Zheng, Yue Chen, Heyang Zhang, Yizhong Ge, Hailun Xie, Jinyu Shi, Li Deng, Shouling Wu, Hanping Shi
    Journal of Cachexia, Sarcopenia and Muscle.2023; 14(6): 2916.     CrossRef
  • Cancer Cachexia: New Insights and Future Directions
    Claudia Raluca Mariean, Oana Mirela Tiucă, Alexandru Mariean, Ovidiu Simion Cotoi
    Cancers.2023; 15(23): 5590.     CrossRef
  • Development and comparative analysis of protein-polyphenol-fibre bars as nutritional supplements suitable for healthy senior consumers
    M. Jolji, B. Pecsenye, Z. Mposula, A. Aleya, T. Kiss, E. Mathé
    Acta Universitatis Sapientiae, Alimentaria.2023; 16(1): 103.     CrossRef
  • Zebrafish as an Emerging Model for Sarcopenia: Considerations, Current Insights, and Future Directions
    Santiago Callegari, Foad Mirzaei, Lila Agbaria, Sanobar Shariff, Burhan Kantawala, Desmond Moronge, Brian M. O. Ogendi
    International Journal of Molecular Sciences.2023; 24(23): 17018.     CrossRef
  • Laboratory markers of osteosarcopenic obesity
    O. V. Gritsenko, O. V. Gruzdeva, G. A. Chumakova, O. L. Barbarash
    Russian Journal of Cardiology.2023; 28(12): 5563.     CrossRef
  • Higher Plasma Stromal Cell-Derived Factor 1 Is Associated with Lower Risk for Sarcopenia in Older Asian Adults
    Sunghwan Ji, Kyunggon Kim, So Jeong Park, Jin Young Lee, Hee-Won Jung, Hyun Ju Yoo, Il-Young Jang, Eunju Lee, Ji Yeon Baek, Beom-Jun Kim
    Endocrinology and Metabolism.2023; 38(6): 701.     CrossRef
  • Familial Correlation and Heritability of Hand Grip Strength in Korean Adults (Korea National Health and Nutrition Examination Survey 2014 to 2019)
    Seong Hee Ahn, Eun Byeol Park, Seongha Seo, Yongin Cho, Da Hea Seo, So Hun Kim, Young Ju Suh, Seongbin Hong
    Endocrinology and Metabolism.2023; 38(6): 709.     CrossRef
  • Ageing with neuromuscular disease: Implications for a lifeworld‐led care through a humanising approach
    Louise Abildgaard Møller, Bente Martinsen, Ulla Werlauf, Pia Dreyer
    Journal of Clinical Nursing.2022; 31(17-18): 2507.     CrossRef
  • CT-derived relationship between low relative muscle mass and bone damage in patients with multiple myeloma undergoing stem cells transplantation
    Alberto Stefano Tagliafico, Federica Rossi, Bianca Bignotti, Lorenzo Torri, Alessandro Bonsignore, Liliana Belgioia, Alida Domineitto
    The British Journal of Radiology.2022;[Epub]     CrossRef
  • A new paradigm in sarcopenia: Cognitive impairment caused by imbalanced myokine secretion and vascular dysfunction
    Danbi Jo, Gwangho Yoon, Oh Yoen Kim, Juhyun Song
    Biomedicine & Pharmacotherapy.2022; 147: 112636.     CrossRef
  • Sarcopenia Is a Cause and Consequence of Metabolic Dysregulation in Aging Humans: Effects of Gut Dysbiosis, Glucose Dysregulation, Diet and Lifestyle
    James W. Daily, Sunmin Park
    Cells.2022; 11(3): 338.     CrossRef
  • Change of Computed Tomography-Based Body Composition after Adrenalectomy in Patients with Pheochromocytoma
    Yousun Ko, Heeryoel Jeong, Seungwoo Khang, Jeongjin Lee, Kyung Won Kim, Beom-Jun Kim
    Cancers.2022; 14(8): 1967.     CrossRef
  • Acute bioenergetic insulin sensitivity of skeletal muscle cells: ATP-demand-provoked glycolysis contributes to stimulation of ATP supply
    Rosie A. Donnell, Jane E. Carré, Charles Affourtit
    Biochemistry and Biophysics Reports.2022; 30: 101274.     CrossRef
  • The Hunt Is On! In Pursuit of the Ideal Stem Cell Population for Cartilage Regeneration
    T. Mark Campbell, F. Jeffrey Dilworth, David S. Allan, Guy Trudel
    Frontiers in Bioengineering and Biotechnology.2022;[Epub]     CrossRef
  • Decreased Serum Level of Sclerostin in Older Adults with Sarcopenia
    Seong Hee Ahn, Hee-Won Jung, Eunju Lee, Ji Yeon Baek, Il-Young Jang, So Jeong Park, Jin Young Lee, Eunah Choi, Yun Sun Lee, Seongbin Hong, Beom-Jun Kim
    Endocrinology and Metabolism.2022; 37(3): 487.     CrossRef
  • Effects of Muscles on Bone Metabolism—with a Focus on Myokines
    Beom-Jun Kim
    Annals of Geriatric Medicine and Research.2022; 26(2): 63.     CrossRef
  • Sclerostin as a Putative Myokine in Sarcopenia
    Hyon-Seung Yi
    Endocrinology and Metabolism.2022; 37(3): 430.     CrossRef
  • Slc12a8 in the lateral hypothalamus maintains energy metabolism and skeletal muscle functions during aging
    Naoki Ito, Ai Takatsu, Hiromi Ito, Yuka Koike, Kiyoshi Yoshioka, Yasutomi Kamei, Shin-ichiro Imai
    Cell Reports.2022; 40(4): 111131.     CrossRef
  • Restoration of NAD+homeostasis protects C2C12 myoblasts and mouse levator ani muscle from mechanical stress-induced damage
    Guotao Huang, Yong He, Li Hong, Min Zhou, Xiaohu Zuo, Zhihan Zhao
    Animal Cells and Systems.2022; 26(4): 192.     CrossRef
  • Machine learning-featured Secretogranin V is a circulating diagnostic biomarker for pancreatic adenocarcinomas associated with adipopenia
    Yunju Jo, Min-Kyung Yeo, Tam Dao, Jeongho Kwon, Hyon‐Seung Yi, Dongryeol Ryu
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Development and Verification of a Combined Diagnostic Model for Sarcopenia with Random Forest and Artificial Neural Network
    Shangjin Lin, Cong Chen, Xiaoxi Cai, Fengjian Yang, Yongqian Fan, Rajesh Kaluri
    Computational and Mathematical Methods in Medicine.2022; 2022: 1.     CrossRef
  • Bronchial Asthma and Sarcopenia: An Upcoming Potential Interaction
    Nikolaos D. Karakousis, Ourania S. Kotsiou, Konstantinos I. Gourgoulianis
    Journal of Personalized Medicine.2022; 12(10): 1556.     CrossRef
  • Suppressive Effects of Turmeric Extract on Muscle Atrophy in Dexamethasone-Treated Mice and Myotubes
    Kyohei Furukawa, Marika Kousaka, Huijuan Jia, Hisanori Kato
    Nutrients.2022; 14(19): 3979.     CrossRef
  • Normative reference values and regression equations to predict the 6-minute walk distance in the Asian adult population aged 21–80 years
    Meredith T. Yeung, Melissa Y. Chan, Katherin S. Huang, Tian Jie Chen, Cyprian P. Chia, Meihiko M. Fong, Cherilyn S. Ho, Derek T. Koh, Mitchell J. Neo, Mark Tan
    Hong Kong Physiotherapy Journal.2022; 42(02): 111.     CrossRef
  • Food insecurity as a risk factor of sarcopenic obesity in older adults
    Diana Fonseca-Pérez, Cecilia Arteaga-Pazmiño, Claudia P. Maza-Moscoso, Sara Flores-Madrid, Ludwig Álvarez-Córdova
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • Transcriptome Sequencing Analysis of circRNA in Skeletal Muscle between Fast- and Slow-Growing Chickens at Embryonic Stages
    Genxi Zhang, Jin Zhang, Pengfei Wu, Xuanze Ling, Qifan Wang, Kaizhi Zhou, Peifeng Li, Li Zhang, Hongxin Ye, Qi Zhang, Qingyu Wei, Tao Zhang, Xinglong Wang
    Animals.2022; 12(22): 3166.     CrossRef
  • Amino Acids in Cancer and Cachexia: An Integrated View
    Maurizio Ragni, Claudia Fornelli, Enzo Nisoli, Fabio Penna
    Cancers.2022; 14(22): 5691.     CrossRef
  • Determination of skeletal muscle mass by aspartate aminotransferase / alanine aminotransferase ratio, insulin and FSH in Chinese women with sarcopenia
    Mengting Yin, He Zhang, Qianhui Liu, Fei Ding, Lisha Hou, Yiping Deng, Tao Cui, Yixian Han, Yijun Chen, Chen Huang, Jirong Yue, Yong He
    BMC Geriatrics.2022;[Epub]     CrossRef
  • The inflammatory response, a mixed blessing for muscle homeostasis and plasticity
    Zineb Bouredji, Anteneh Argaw, Jérôme Frenette
    Frontiers in Physiology.2022;[Epub]     CrossRef
  • Effect of CCL11 on In Vitro Myogenesis and Its Clinical Relevance for Sarcopenia in Older Adults
    Da Ae Kim, So Jeong Park, Jin Young Lee, Jeoung Hee Kim, Seungjoo Lee, Eunju Lee, Il-Young Jang, Hee-Won Jung, Jin Hoon Park, Beom-Jun Kim
    Endocrinology and Metabolism.2021; 36(2): 455.     CrossRef
  • Association of Water Intake with Hand Grip Strength in Community-Dwelling Older Adults
    Hyeonmok Kim, Sun Hee Beom, Tae Ho Kim, Beom-Jun Kim
    Nutrients.2021; 13(6): 1756.     CrossRef
  • Receptor-Mediated Muscle Homeostasis as a Target for Sarcopenia Therapeutics
    Jong Hyeon Yoon, Ki-Sun Kwon
    Endocrinology and Metabolism.2021; 36(3): 478.     CrossRef
  • Redox Signaling and Sarcopenia: Searching for the Primary Suspect
    Nicholas A. Foreman, Anton S. Hesse, Li Li Ji
    International Journal of Molecular Sciences.2021; 22(16): 9045.     CrossRef
  • Aldosterone Inhibits In Vitro Myogenesis by Increasing Intracellular Oxidative Stress via Mineralocorticoid Receptor
    Jin Young Lee, Da Ae Kim, Eunah Choi, Yun Sun Lee, So Jeong Park, Beom-Jun Kim
    Endocrinology and Metabolism.2021; 36(4): 865.     CrossRef
  • Artificial‐intelligence‐driven discovery of prognostic biomarker for sarcopenia
    Heewon Chung, Yunju Jo, Dongryeol Ryu, Changwon Jeong, Seong‐Kyu Choe, Jinseok Lee
    Journal of Cachexia, Sarcopenia and Muscle.2021; 12(6): 2220.     CrossRef
  • Association between Neurologic Outcomes and Changes of Muscle Mass Measured by Brain Computed Tomography in Neurocritically Ill Patients
    Yun Im Lee, Ryoung-Eun Ko, Joonghyun Ahn, Keumhee C. Carriere, Jeong-Am Ryu
    Journal of Clinical Medicine.2021; 11(1): 90.     CrossRef
  • Computed Tomography-Derived Skeletal Muscle Radiodensity Is an Early, Sensitive Marker of Age-Related Musculoskeletal Changes in Healthy Adults
    Yeon Woo Jung, Namki Hong, Joon Chae Na, Woong Kyu Han, Yumie Rhee
    Endocrinology and Metabolism.2021; 36(6): 1201.     CrossRef
Close layer
Obesity and Metabolism
Implications of Mitochondrial Unfolded Protein Response and Mitokines: A Perspective on Fatty Liver Diseases
Hyon-Seung Yi
Endocrinol Metab. 2019;34(1):39-46.   Published online March 21, 2019
DOI: https://doi.org/10.3803/EnM.2019.34.1.39
  • 5,862 View
  • 140 Download
  • 25 Web of Science
  • 25 Crossref
AbstractAbstract PDFPubReader   ePub   

The signaling network of the mitochondrial unfolded protein response (UPRmt) and mitohormesis is a retrograde signaling pathway through which mitochondria-to-nucleus communication occurs in organisms. Recently, it has been shown that the UPRmt is closely associated with metabolic disorders and conditions involving insulin resistance, such as alcoholic and non-alcoholic fatty liver and fibrotic liver disease. Scientific efforts to understand the UPRmt and mitohormesis, as well as to establish the mitochondrial proteome, have established the importance of mitochondrial quality control in the development and progression of metabolic liver diseases, including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). In this review, we integrate and discuss the recent data from the literature on the UPRmt and mitohormesis in metabolic liver diseases, including NAFLD/NASH and fibrosis.

Citations

Citations to this article as recorded by  
  • Aberrant mitochondrial aggregation of TDP-43 activated mitochondrial unfolded protein response and contributed to recovery of acetaminophen induced acute liver injury
    Zhaoxiong Liu, Yalong Qiang, Shulin Shan, Shuai Wang, Zhidan Liu, Yiyu Yang, Zhengcheng Huang, Mingxue Song, Xiulan Zhao, Fuyong Song
    Toxicology Research.2024;[Epub]     CrossRef
  • Autophagy and the unfolded protein response shape the non-alcoholic fatty liver landscape: decoding the labyrinth
    Zahra Dashti, Zeynab Yousefi, Pouria Kiani, Motahareh Taghizadeh, Mohammad Hasan Maleki, Mohammad Borji, Omid Vakili, Sayed Mohammad Shafiee
    Metabolism.2024; 154: 155811.     CrossRef
  • Recent progress in understanding mitokines as diagnostic and therapeutic targets in hepatocellular carcinoma
    Jiang Wang, Lan-Zhu Luo, Dao-Miao Liang, Chao Guo, Zhi-Hong Huang, Xiao-Hong Jian, Jie Wen
    World Journal of Clinical Cases.2023; 11(23): 5416.     CrossRef
  • From Non-Alcoholic Fatty Liver to Hepatocellular Carcinoma: A Story of (Mal)Adapted Mitochondria
    Ricardo Amorim, Carina C. Magalhães, Fernanda Borges, Paulo J. Oliveira, José Teixeira
    Biology.2023; 12(4): 595.     CrossRef
  • Natural Drugs: A New Direction for the Prevention and Treatment of Diabetes
    Peishan Wu, Xiaolei Wang
    Molecules.2023; 28(14): 5525.     CrossRef
  • Mitochondrial Quality Control via Mitochondrial Unfolded Protein Response (mtUPR) in Ageing and Neurodegenerative Diseases
    Paula Cilleros-Holgado, David Gómez-Fernández, Rocío Piñero-Pérez, Jose Manuel Romero-Domínguez, Diana Reche-López, Alejandra López-Cabrera, Mónica Álvarez-Córdoba, Manuel Munuera-Cabeza, Marta Talaverón-Rey, Alejandra Suárez-Carrillo, Ana Romero-González
    Biomolecules.2023; 13(12): 1789.     CrossRef
  • Heat Shock Protein 60 Restricts Release of Mitochondrial dsRNA to Suppress Hepatic Inflammation and Ameliorate Non-Alcoholic Fatty Liver Disease in Mice
    Ying-Hsien Huang, Feng-Sheng Wang, Pei-Wen Wang, Hung-Yu Lin, Sheng-Dean Luo, Ya-Ling Yang
    International Journal of Molecular Sciences.2022; 23(1): 577.     CrossRef
  • UPRmt activation improves pathological alterations in cellular models of mitochondrial diseases
    Juan M. Suárez-Rivero, Carmen J. Pastor-Maldonado, Suleva Povea-Cabello, Mónica Álvarez-Córdoba, Irene Villalón-García, Marta Talaverón-Rey, Alejandra Suárez-Carrillo, Manuel Munuera-Cabeza, Diana Reche-López, Paula Cilleros-Holgado, Rocío Piñero-Perez, J
    Orphanet Journal of Rare Diseases.2022;[Epub]     CrossRef
  • Umbilical Cord-Mesenchymal Stem Cell-Conditioned Medium Improves Insulin Resistance in C2C12 Cell
    Kyung-Soo Kim, Yeon Kyung Choi, Mi Jin Kim, Jung Wook Hwang, Kyunghoon Min, Sang Youn Jung, Soo-Kyung Kim, Yong-Soo Choi, Yong-Wook Cho
    Diabetes & Metabolism Journal.2021; 45(2): 260.     CrossRef
  • Mitochondrial unfolded protein response: An emerging pathway in human diseases
    Li Zhu, Qionglin Zhou, Lu He, Linxi Chen
    Free Radical Biology and Medicine.2021; 163: 125.     CrossRef
  • Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending?
    Miriam Longo, Marica Meroni, Erika Paolini, Chiara Macchi, Paola Dongiovanni
    Metabolism.2021; 117: 154708.     CrossRef
  • Mitochondrial unfolded protein response: A novel pathway in metabolism and immunity
    Li Zhu, Xuling Luo, Nian Fu, Linxi Chen
    Pharmacological Research.2021; 168: 105603.     CrossRef
  • Mitochondrial Metabolic Signatures in Hepatocellular Carcinoma
    Ho-Yeop Lee, Ha Thi Nga, Jingwen Tian, Hyon-Seung Yi
    Cells.2021; 10(8): 1901.     CrossRef
  • Cnm1 mediates nucleus–mitochondria contact site formation in response to phospholipid levels
    Michal Eisenberg-Bord, Naama Zung, Javier Collado, Layla Drwesh, Emma J. Fenech, Amir Fadel, Nili Dezorella, Yury S. Bykov, Doron Rapaport, Ruben Fernandez-Busnadiego, Maya Schuldiner
    Journal of Cell Biology.2021;[Epub]     CrossRef
  • The Role of Carnitine Orotate Complex in Fatty Liver
    Hyon-Seung Yi
    Diabetes & Metabolism Journal.2021; 45(6): 866.     CrossRef
  • Serum GDF15 Level Is Independent of Sarcopenia in Older Asian Adults
    Ha Thi Nga, Il-Young Jang, Da Ae Kim, So Jeong Park, Jin Young Lee, Seungjoo Lee, Jeoung Hee Kim, Eunju Lee, Jin Hoon Park, Young-Ho Lee, Hyon-Seung Yi, Beom-Jun Kim
    Gerontology.2021; 67(5): 525.     CrossRef
  • Exogenous Therapeutics of Microrna-29a Attenuates Development of Hepatic Fibrosis in Cholestatic Animal Model through Regulation of Phosphoinositide 3-Kinase p85 Alpha
    Ya-Ling Yang, Feng-Sheng Wang, Hung-Yu Lin, Ying-Hsien Huang
    International Journal of Molecular Sciences.2020; 21(10): 3636.     CrossRef
  • High-altitude chronic hypoxia ameliorates obesity-induced non-alcoholic fatty liver disease in mice by regulating mitochondrial and AMPK signaling
    Kang Song, Yifan Zhang, Qin Ga, Zhenzhong Bai, Ri-Li Ge
    Life Sciences.2020; 252: 117633.     CrossRef
  • NRF-2 and nonalcoholic fatty liver disease
    Arturo Solano-Urrusquieta, José A. Morales-González, Graciela E. Castro-Narro, Eira Cerda-Reyes, Perla D. Flores-Rangel, Raul Fierros-Oceguera
    Annals of Hepatology.2020; 19(5): 458.     CrossRef
  • Mitochondrial Quality Control in the Heart: New Drug Targets for Cardiovascular Disease
    Chang-Myung Oh, Dongryeol Ryu, Sungsoo Cho, Yangsoo Jang
    Korean Circulation Journal.2020; 50(5): 395.     CrossRef
  • Growth differentiation factor 15 protects against the aging‐mediated systemic inflammatory response in humans and mice
    Ji Sun Moon, Ludger J. E. Goeminne, Jung Tae Kim, Jing Wen Tian, Seok‐Hwan Kim, Ha Thi Nga, Seul Gi Kang, Baeki E. Kang, Jin‐Seok Byun, Young‐Sun Lee, Jae‐Han Jeon, Minho Shong, Johan Auwerx, Dongryeol Ryu, Hyon‐Seung Yi
    Aging Cell.2020;[Epub]     CrossRef
  • miR-29a Modulates GSK3β/SIRT1-Linked Mitochondrial Proteostatic Stress to Ameliorate Mouse Non-Alcoholic Steatohepatitis
    Ya-Ling Yang, Pei-Wen Wang, Feng-Sheng Wang, Hung-Yu Lin, Ying-Hsien Huang
    International Journal of Molecular Sciences.2020; 21(18): 6884.     CrossRef
  • Impact of Mitophagy and Mitochondrial Unfolded Protein Response as New Adaptive Mechanisms Underlying Old Pathologies: Sarcopenia and Non-Alcoholic Fatty Liver Disease
    Rodrigo Urbina-Varela, Nataly Castillo, Luis A. Videla, Andrea del Campo
    International Journal of Molecular Sciences.2020; 21(20): 7704.     CrossRef
  • Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease
    Jin Lee, Jeong-Su Park, Yoon Seok Roh
    Archives of Pharmacal Research.2019; 42(11): 935.     CrossRef
  • A siRNA mediated hepatic dpp4 knockdown affects lipid, but not glucose metabolism in diabetic mice
    Sven Wolfgang Görgens, Kerstin Jahn-Hofmann, Dinesh Bangari, Sheila Cummings, Christiane Metz-Weidmann, Uwe Schwahn, Paulus Wohlfart, Matthias Schäfer, Maximilian Bielohuby, Marcia B. Aguila
    PLOS ONE.2019; 14(12): e0225835.     CrossRef
Close layer
Original Article
Endocrine Research
Deficiency of Sphingosine-1-Phosphate Reduces the Expression of Prohibitin and Causes β-Cell Impairment via Mitochondrial Dysregulation
Seok-Woo Hong, Jinmi Lee, Hyemi Kwon, Se Eun Park, Eun-Jung Rhee, Cheol-Young Park, Ki-Won Oh, Sung-Woo Park, Won-Young Lee
Endocrinol Metab. 2018;33(3):403-412.   Published online September 18, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.3.403
  • 4,192 View
  • 50 Download
  • 16 Web of Science
  • 16 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Emerging evidence suggests that sphingolipids may be involved in type 2 diabetes. However, the exact signaling defect through which disordered sphingolipid metabolism induces β-cell dysfunction remains unknown. The current study demonstrated that sphingosine-1-phosphate (S1P), the product of sphingosine kinase (SphK), is an essential factor for maintaining β-cell function and survival via regulation of mitochondrial action, as mediated by prohibitin (PHB).

Methods

We examined β-cell function and viability, as measured by mitochondrial function, in mouse insulinoma 6 (MIN6) cells in response to manipulation of cellular S1P and PHB levels.

Results

Lack of S1P induced by sphingosine kinase inhibitor (SphKi) treatment caused β-cell dysfunction and apoptosis, with repression of mitochondrial function shown by decreases in cellular adenosine triphosphate content, the oxygen consumption rate, the expression of oxidative phosphorylation complexes, the mitochondrial membrane potential, and the expression of key regulators of mitochondrial dynamics (mitochondrial dynamin-like GTPase [OPA1] and mitofusin 1 [MFN1]). Supplementation of S1P led to the recovery of mitochondrial function and greatly improved β-cell function and viability. Knockdown of SphK2 using small interfering RNA induced mitochondrial dysfunction, decreased glucose-stimulated insulin secretion (GSIS), and reduced the expression of PHB, an essential regulator of mitochondrial metabolism. PHB deficiency significantly reduced GSIS and induced mitochondrial dysfunction, and co-treatment with S1P did not reverse these trends.

Conclusion

Altogether, these data suggest that S1P is an essential factor in the maintenance of β-cell function and survival through its regulation of mitochondrial action and PHB expression.

Citations

Citations to this article as recorded by  
  • Mitochondrial Cristae Morphology Reflecting Metabolism, Superoxide Formation, Redox Homeostasis, and Pathology
    Petr Ježek, Martin Jabůrek, Blanka Holendová, Hana Engstová, Andrea Dlasková
    Antioxidants & Redox Signaling.2023; 39(10-12): 635.     CrossRef
  • Sphingolipids in mitochondria—from function to disease
    Maryam Jamil, Lauren Ashley Cowart
    Frontiers in Cell and Developmental Biology.2023;[Epub]     CrossRef
  • Sphingosine‐1‐phosphate in mitochondrial function and metabolic diseases
    Meng Duan, Pan Gao, Sheng‐xi Chen, Petr Novák, Kai Yin, Xiao Zhu
    Obesity Reviews.2022;[Epub]     CrossRef
  • Involvement of miR‐27a‐3p in diabetic nephropathy via affecting renal fibrosis, mitochondrial dysfunction, and endoplasmic reticulum stress
    Lina Wu, Qingzhu Wang, Feng Guo, Xiaojun Ma, Jiao Wang, Yanyan Zhao, Yushan Yan, Guijun Qin
    Journal of Cellular Physiology.2021; 236(2): 1454.     CrossRef
  • Sphingosine‐1‐phosphate in acute exercise and training
    Katarzyna Hodun, Adrian Chabowski, Marcin Baranowski
    Scandinavian Journal of Medicine & Science in Sports.2021; 31(5): 945.     CrossRef
  • The Ethyl Acetate Extract From Celastrus orbiculatus Promotes Apoptosis of Gastric Cancer Cells Through Mitochondria Regulation by PHB
    Lide Tao, Zixin Yin, Tengyang Ni, Zewen Chu, Shihua Hao, Zeyu Wang, Masataka Sunagawa, Haibo Wang, Yanqing Liu
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • Sphingosine 1-phosphate Stimulates Insulin Secretion and Improves Cell Survival by Blocking Voltage-dependent K+ Channels in β Cells
    Zhihong Liu, Huanhuan Yang, Linping Zhi, Huan Xue, Zhihong Lu, Yanli Zhao, Lijuan Cui, Tao Liu, Shouan Ren, Peifeng He, Yunfeng Liu, Yi Zhang
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • Sphingosine-1 Phosphate Lyase Regulates Sensitivity of Pancreatic Beta-Cells to Lipotoxicity
    Yadi Tang, Thomas Plötz, Markus H. Gräler, Ewa Gurgul-Convey
    International Journal of Molecular Sciences.2021; 22(19): 10893.     CrossRef
  • Sphingolipids and Mitochondrial Dynamic
    Lais Brigliadori Fugio, Fernanda B. Coeli-Lacchini, Andréia Machado Leopoldino
    Cells.2020; 9(3): 581.     CrossRef
  • Diminished Sphingolipid Metabolism, a Hallmark of Future Type 2 Diabetes Pathogenesis, Is Linked to Pancreatic β Cell Dysfunction
    Saifur R. Khan, Yousef Manialawy, Andreea Obersterescu, Brian J. Cox, Erica P. Gunderson, Michael B. Wheeler
    iScience.2020; 23(10): 101566.     CrossRef
  • Neuronal Metabolism and Neuroprotection: Neuroprotective Effect of Fingolimod on Menadione-Induced Mitochondrial Damage
    Antonio Gil, Elisa Martín-Montañez, Nadia Valverde, Estrella Lara, Federica Boraldi, Silvia Claros, Silvana-Yanina Romero-Zerbo, Oscar Fernández, Jose Pavia, Maria Garcia-Fernandez
    Cells.2020; 10(1): 34.     CrossRef
  • WITHDRAWN: Ceramide and Sphingosine 1-Phosphate in adipose dysfunction
    Zijian Fang, Susan Pyne, Nigel J. Pyne
    Progress in Lipid Research.2019; : 100991.     CrossRef
  • Dynamic of mitochondrial network, cristae, and mitochondrial nucleoids in pancreatic β-cells
    Petr Ježek, Andrea Dlasková
    Mitochondrion.2019; 49: 245.     CrossRef
  • Sphingosine kinase 1 overexpression induces MFN2 fragmentation and alters mitochondrial matrix Ca2+ handling in HeLa cells
    I. Pulli, C. Löf, T. Blom, M.Y. Asghar, T. Lassila, N. Bäck, K.-L. Lin, J.H. Nyström, K. Kemppainen, D.M. Toivola, E. Dufour, A. Sanz, H.M. Cooper, J.B. Parys, K. Törnquist
    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.2019; 1866(9): 1475.     CrossRef
  • Ceramide and sphingosine 1-phosphate in adipose dysfunction
    Zijian Fang, Susan Pyne, Nigel J. Pyne
    Progress in Lipid Research.2019; 74: 145.     CrossRef
  • S1P/S1P Receptor Signaling in Neuromuscolar Disorders
    Elisabetta Meacci, Mercedes Garcia-Gil
    International Journal of Molecular Sciences.2019; 20(24): 6364.     CrossRef
Close layer
Review Article
Diabetes-Related Cardiac Dysfunction
Lamario J. Williams, Brenna G. Nye, Adam R. Wende
Endocrinol Metab. 2017;32(2):171-179.   Published online June 23, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.2.171
  • 12,180 View
  • 45 Download
  • 37 Web of Science
  • 36 Crossref
AbstractAbstract PDFPubReader   ePub   

The proposal that diabetes plays a role in the development of heart failure is supported by the increased risk associated with this disease, even after correcting for all other known risk factors. However, the precise mechanisms contributing to the condition referred to as diabetic cardiomyopathy have remained elusive, as does defining the disease itself. Decades of study have defined numerous potential factors that each contribute to disease susceptibility, progression, and severity. Many recent detailed reviews have been published on mechanisms involving insulin resistance, dysregulation of microRNAs, and increased reactive oxygen species, as well as causes including both modifiable and non-modifiable risk factors. As such, the focus of the current review is to highlight aspects of each of these topics and to provide specific examples of recent advances in each area.

Citations

Citations to this article as recorded by  
  • Upregulation of PCSK9, rho kinase and cardiac troponin by Eucalyptus globulus leaf extract improves fructose-streptozotocin-induced diabetic cardiac dysfunction in rats
    Afolabi C. Akinmoladun, Morenikejimi Bello, Emmanuel Oluwafemi Ibukun
    Archives of Physiology and Biochemistry.2023; 129(6): 1219.     CrossRef
  • An Overview of Cardiotonic Medicinal Plants from the Perspective of Iranian Traditional Medicine
    Akram Alembagheri, Homa Hajimehdipoor, Rasool Choopani, Somayeh Esmaeili
    Jundishapur Journal of Natural Pharmaceutical Products.2023;[Epub]     CrossRef
  • Nanoformulations for the Delivery of Dietary Anthocyanins for the Prevention and Treatment of Diabetes Mellitus and Its Complications
    Ana R. Nunes, Elisabete C. Costa, Gilberto Alves, Luís R. Silva
    Pharmaceuticals.2023; 16(5): 736.     CrossRef
  • Cyp2e1 knockdown attenuates high glucose-induced apoptosis and oxidative stress of cardiomyocytes by activating PI3K/Akt signaling
    Jianying Wang, Han Yang, Chao Wang, Cuie Kan
    Acta Diabetologica.2023; 60(9): 1219.     CrossRef
  • Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value
    Yu-Qi Li, Lei Xin, Yu-Chi Zhao, Shang-Qi Li, Ya-Nuo Li
    World Journal of Hepatology.2023; 15(6): 786.     CrossRef
  • Non-Invasive Assessment of the Intraventricular Pressure Using Novel Color M-Mode Echocardiography in Animal Studies: Current Status and Future Perspectives in Veterinary Medicine
    Ahmed S. Mandour, Ahmed Farag, Mahmoud A. Y. Helal, Gamal El-Masry, Salim Al-Rejaie, Ken Takahashi, Tomohiko Yoshida, Lina Hamabe, Ryou Tanaka
    Animals.2023; 13(15): 2452.     CrossRef
  • Diet‐induced prediabetes: Effects on the activity of the renin–angiotensin–aldosterone system in selected organs
    Bongeka Cassandra Mkhize, Palesa Mosili, Phikelelani Sethu Ngubane, Ntethelelo Hopewell Sibiya, Andile Khathi
    Journal of Diabetes Investigation.2022; 13(5): 768.     CrossRef
  • Knowledge domain and emerging trends in diabetic cardiomyopathy: A scientometric review based on CiteSpace analysis
    Shiyi Tao, Deshuang Yang, Lanxin Zhang, Lintong Yu, Zihan Wang, Lingling Li, Jin Zhang, Ruiqi Yao, Li Huang, Mingjing Shao
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Sodium–Glucose Co-transporter-2 Inhibitors
    Joshua J Neumiller, Fredrick J Lienhard, Radica Z Alicic, Katherine R Tuttle
    European Endocrinology.2022; 18(2): 106.     CrossRef
  • Protective effects of medicinal plant against diabetes induced cardiac disorder: A review
    Sadegh Shabab, Zahra Gholamnezhad, Maryam Mahmoudabady
    Journal of Ethnopharmacology.2021; 265: 113328.     CrossRef
  • Toward a broader view of mechanisms of drug cardiotoxicity
    Polina Mamoshina, Blanca Rodriguez, Alfonso Bueno-Orovio
    Cell Reports Medicine.2021; 2(3): 100216.     CrossRef
  • Cardioprotective Effect of Glycyrrhizin on Myocardial Remodeling in Diabetic Rats
    Vikram Thakur, Narah Alcoreza, Monica Delgado, Binata Joddar, Munmun Chattopadhyay
    Biomolecules.2021; 11(4): 569.     CrossRef
  • Cardioprotective Action of Glycyrrhizin on Diabetic Rats with Myocardial Remodeling
    Fuxu Chen, Jie Song, Enas Abdulhay
    Journal of Healthcare Engineering.2021; 2021: 1.     CrossRef
  • Management of inflammation in cardiovascular diseases
    Sumanta Kumar Goswami, Prabhat Ranjan, Roshan Kumar Dutta, Suresh Kumar Verma
    Pharmacological Research.2021; 173: 105912.     CrossRef
  • Diabetic Cardiomyopathy: Clinical and Metabolic Approach
    Dragan B. Djordjevic, Goran Koracevic, Aleksandar D. Djordjevic, Dragan B. Lovic
    Current Vascular Pharmacology.2021; 19(5): 487.     CrossRef
  • Effect of Acute Chemotherapy on Glucose Levels in Rats
    Ahmad H. Alhowail, Gena S. Alfawzan, Maha A. Aldubayan, Lolwah S. Alsalam
    International Journal of Pharmacology.2020; 16(3): 276.     CrossRef
  • Transplantation of adipose tissue lacking PAI-1 improves glucose tolerance and attenuates cardiac metabolic abnormalities in high-fat diet-induced obesity
    Sijing Liu, Yi Li, Xin Fan, Kai Li, Chunrong Xu, Liping Zhang, Mao Luo, Liqun Wang, Rong Li, Jianbo Wu
    Adipocyte.2020; 9(1): 170.     CrossRef
  • Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers
    Jeffrey I. Mechanick, Michael E. Farkouh, Jonathan D. Newman, W. Timothy Garvey
    Journal of the American College of Cardiology.2020; 75(5): 525.     CrossRef
  • Associated Targets of the Antioxidant Cardioprotection of Ganoderma lucidum in Diabetic Cardiomyopathy by Using Open Targets Platform: A Systematic Review
    Fahmi Shaher, Hongbin Qiu, Shuqiu Wang, Yu Hu, Weiqun Wang, Yu Zhang, Yao Wei, Hisham AL-ward, Mahfoudh A. M. Abdulghani, Sattam Khulaif Alenezi, Salem Baldi, Shaobo Zhou
    BioMed Research International.2020; 2020: 1.     CrossRef
  • Human trophoblast-derived exosomes attenuate doxorubicin-induced cardiac injury by regulating miR-200b and downstream Zeb1
    Jie Ni, Yihai Liu, Lina Kang, Lian Wang, Zhonglin Han, Kun Wang, Biao Xu, Rong Gu
    Journal of Nanobiotechnology.2020;[Epub]     CrossRef
  • Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Glucagon-like Peptide-1 Receptor Agonists
    Emily J Cox, Radica Z Alicic, Joshua J Neumiller, Katherine R Tuttle
    US Endocrinology.2020; 16(2): 80.     CrossRef
  • Hyperbaric Oxygen Therapy Dampens Inflammatory Cytokine Production and Does Not Worsen the Cardiac Function and Oxidative State of Diabetic Rats
    Rita Benkő, Zsuzsanna Miklós, Viktor Antal Ágoston, Katrine Ihonvien, Csaba Répás, Roland Csépányi-Kömi, Margit Kerék, Nóra Judit Béres, Eszter Mária Horváth
    Antioxidants.2019; 8(12): 607.     CrossRef
  • Heart Failure in Type 2 Diabetes Mellitus
    Helena C. Kenny, E. Dale Abel
    Circulation Research.2019; 124(1): 121.     CrossRef
  • SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice
    Damilola D. Adingupu, Sven O. Göpel, Julia Grönros, Margareta Behrendt, Matus Sotak, Tasso Miliotis, Ulrika Dahlqvist, Li-Ming Gan, Ann-Cathrine Jönsson-Rylander
    Cardiovascular Diabetology.2019;[Epub]     CrossRef
  • Depressive symptoms in asymptomatic stage B heart failure with Type II diabetic mellitus
    Paul J. Mills, Pam R. Taub, Ottar Lunde, Meredith A. Pung, Kathleen Wilson, Christopher Pruitt, Thomas Rutledge, Alan Maisel, Barry H. Greenberg
    Clinical Cardiology.2019; 42(6): 637.     CrossRef
  • Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate
    Amir M. Al Hroob, Mohammad H. Abukhalil, Omnia E. Hussein, Ayman M. Mahmoud
    Biomedicine & Pharmacotherapy.2019; 109: 2155.     CrossRef
  • The Janus face of HMGB1 in heart disease: a necessary update
    Angela Raucci, Stefania Di Maggio, Francesco Scavello, Alessandro D’Ambrosio, Marco E. Bianchi, Maurizio C. Capogrossi
    Cellular and Molecular Life Sciences.2019; 76(2): 211.     CrossRef
  • Histological evidence of chitosan-encapsulated curcumin suppresses heart and kidney damages on streptozotocin-induced type-1 diabetes in mice model
    Sabri Sudirman, Ching-Shu Lai, Yi-Ling Yan, Hung-I Yeh, Zwe-Ling Kong
    Scientific Reports.2019;[Epub]     CrossRef
  • Microarray profiling analysis identifies the mechanism of miR‐200b‐3p/mRNA‐CD36 affecting diabetic cardiomyopathy via peroxisome proliferator activated receptor‐γ signaling pathway
    Liqiong Xu, Wei Chen, Min Ma, Anfang Chen, Chengyue Tang, Chengwei Zhang, Lin Cai
    Journal of Cellular Biochemistry.2019; 120(4): 5193.     CrossRef
  • Plasma Low-Density Lipoprotein Cholesterol Correlates With Heart Function in Individuals With Type 2 Diabetes Mellitus: A Cross-Sectional Study
    Po-Chung Cheng, Shang-Ren Hsu, Jung-Chi Li, Ching-Pei Chen, Szu-Chi Chien, Shih-Te Tu, Yun-Chung Cheng, Yu-Hsiu Liu, Jeng-Fu Kuo
    Frontiers in Endocrinology.2019;[Epub]     CrossRef
  • Impact of diabetes mellitus on the contractile properties of the left and right atrial myofilaments†
    Constanze Bening, Khaled Alhussini, Elena-Aura Mazalu, Jonathan Yaqub, Khaled Hamouda, Dejan Radakovic, Christoph Schimmer, Grzegorz Hirnle, Rainer Leyh
    European Journal of Cardio-Thoracic Surgery.2018; 54(5): 826.     CrossRef
  • LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21/PPARa signaling
    Lu Gao, Yuan Liu, Sen Guo, Lili Xiao, Leiming Wu, Zheng Wang, Cui Liang, Rui Yao, Yanzhou Zhang
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2018; 1864(10): 3322.     CrossRef
  • Gene expression profiles of rat MMECs with different glucose levels and fgl2 gene silencing
    Zhenzhong Zheng, Fan Zhang, Dengpeng Gao, Yujing Wu, Hao Wu
    Diabetes/Metabolism Research and Reviews.2018;[Epub]     CrossRef
  • Empagliflozin Ammeliorates High Glucose Induced-Cardiac Dysfuntion in Human iPSC-Derived Cardiomyocytes
    Kwong-Man Ng, Yee-Man Lau, Vidhu Dhandhania, Zhu-Jun Cai, Yee-Ki Lee, Wing-Hon Lai, Hung-Fat Tse, Chung-Wah Siu
    Scientific Reports.2018;[Epub]     CrossRef
  • Apelin‑13 ameliorates metabolic and cardiovascular disorders in a rat model of type 2 diabetes with a high‑fat diet
    Meng Li, Huijuan Fang, Jian Hu
    Molecular Medicine Reports.2018;[Epub]     CrossRef
  • Adriamycin-induced cardiomyopathy can serve as a model for diabetic cardiomyopathy – a hypothesis
    Kaviyarasi Renu, V.G. Abilash, P.B. Tirupathi Pichiah, Thabassum Akthar Syeda, Sankarganesh Arunachalam
    Asian Pacific Journal of Tropical Biomedicine.2017; 7(11): 1041.     CrossRef
Close layer
Original Article
Endocrine Research
The Effects of High Fat Diet and Resveratrol on Mitochondrial Activity of Brown Adipocytes
Cheol Ryong Ku, Yoon Hee Cho, Zhen-Yu Hong, Ha Lee, Sue Ji Lee, Seung-soo Hong, Eun Jig Lee
Endocrinol Metab. 2016;31(2):328-335.   Published online April 8, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.2.328
  • 4,132 View
  • 50 Download
  • 25 Web of Science
  • 25 Crossref
AbstractAbstract PDFPubReader   
Background

Resveratrol (RSV) is a polyphenolic phytoalexin that has many effects on metabolic diseases such as diabetes and obesity. Given the importance of brown adipose tissue (BAT) for energy expenditure, we investigated the effects of RSV on brown adipocytes.

Methods

For the in vitro study, interscapular BAT was isolated from 7-week-old male Sprague Dawley rats. For the in vivo study, 7-week-old male Otsuka Long Evans Tokushima Fatty (OLETF) rats were divided into four groups and treated for 27 weeks with: standard diet (SD); SD+RSV (10 mg/kg body weight, daily); high fat diet (HFD); HFD+RSV. RSV was provided via oral gavage once daily during the in vivo experiments.

Results

RSV treatment of primary cultured brown preadipocytes promoted mitochondrial activity, along with over-expression of estrogen receptor α (ER-α). In OLETF rats, both HFD and RSV treatment increased the weight of BAT and the differentiation of BAT. However, only RSV increased the mitochondrial activity and ER-α expression of BAT in the HFD-fed group. Finally, RSV improved the insulin sensitivity of OLETF rats by increasing the mitochondrial activity of BAT, despite having no effects on white adipocytes and muscles in either diet group.

Conclusion

RSV could improve insulin resistance, which might be associated with mitochondrial activity of brown adipocyte. Further studies evaluating the activity of RSV for both the differentiation and mitochondrial activity of BAT could be helpful in investigating the effects of RSV on metabolic parameters.

Citations

Citations to this article as recorded by  
  • Natural Bioactive Compounds from Foods Inhibited Pigmentation Especially Potential Application of Fucoxanthin to Chloasma: a Mini-Review
    Yida Wang, Hang Qi
    Food Reviews International.2024; 40(1): 20.     CrossRef
  • Resveratrol combats chronic diseases through enhancing mitochondrial quality
    Weichu Tao, Hu Zhang, Xia Jiang, Ning Chen
    Food Science and Human Wellness.2024; 13(2): 597.     CrossRef
  • The Potential to Fight Obesity with Adipogenesis Modulating Compounds
    Jiaqi Zhao, Ailin Zhou, Wei Qi
    International Journal of Molecular Sciences.2022; 23(4): 2299.     CrossRef
  • Macrophage and Adipocyte Mitochondrial Dysfunction in Obesity-Induced Metabolic Diseases
    Liwen Wang, Jie Hu, Haiyan Zhou
    The World Journal of Men's Health.2021; 39(4): 606.     CrossRef
  • Precision Nutrition to Activate Thermogenesis as a Complementary Approach to Target Obesity and Associated-Metabolic-Disorders
    Marina Reguero, Marta Gómez de Cedrón, Sonia Wagner, Guillermo Reglero, José Carlos Quintela, Ana Ramírez de Molina
    Cancers.2021; 13(4): 866.     CrossRef
  • Natural Antioxidant Application on Fat Accumulation: Preclinical Evidence
    Proshanta Roy, Daniele Tomassoni, Enea Traini, Ilenia Martinelli, Maria Vittoria Micioni Di Bonaventura, Carlo Cifani, Francesco Amenta, Seyed Khosrow Tayebati
    Antioxidants.2021; 10(6): 858.     CrossRef
  • Activation of Brown Adipose Tissue and Promotion of White Adipose Tissue Browning by Plant-based Dietary Components in Rodents: A Systematic Review
    Francisco J Osuna-Prieto, Borja Martinez-Tellez, Antonio Segura-Carretero, Jonatan R Ruiz
    Advances in Nutrition.2021; 12(6): 2147.     CrossRef
  • Role of Dietary Polyphenols in Adipose Tissue Browning: A Narrative Review
    Juan Salazar, Clímaco Cano, José L. Pérez, Ana Castro, María P. Díaz, Bermary Garrido, Rubén Carrasquero, Maricarmen Chacín, Manuel Velasco, Luis D´Marco, Joselyn Rojas-Quintero, Valmore Bermúdez
    Current Pharmaceutical Design.2020; 26(35): 4444.     CrossRef
  • Brown and Brite: The Fat Soldiers in the Anti-obesity Fight
    Shireesh Srivastava, Richard L. Veech
    Frontiers in Physiology.2019;[Epub]     CrossRef
  • Effect of resveratrol on adipokines and myokines involved in fat browning: Perspectives in healthy weight against obesity
    Oh Yoen Kim, Ji Yeon Chung, Juhyun Song
    Pharmacological Research.2019; 148: 104411.     CrossRef
  • Ginsenoside Rb2 Alleviates Obesity by Activation of Brown Fat and Induction of Browning of White Fat
    Yilian Hong, Yi Lin, Qiya Si, Lijuan Yang, Weisong Dong, Xuejiang Gu
    Frontiers in Endocrinology.2019;[Epub]     CrossRef
  • Programming of the Beige Phenotype in White Adipose Tissue of Adult Mice by Mild Resveratrol and Nicotinamide Riboside Supplementations in Early Postnatal Life
    Alba Serrano, Madhu Asnani-Kishnani, Ana María Rodríguez, Andreu Palou, Joan Ribot, María Luisa Bonet
    Molecular Nutrition & Food Research.2018;[Epub]     CrossRef
  • Effects of Polyphenols on Thermogenesis and Mitochondrial Biogenesis
    Tanila Wood dos Santos, Quélita Cristina Pereira, Lucimara Teixeira, Alessandra Gambero, Josep A. Villena, Marcelo Lima Ribeiro
    International Journal of Molecular Sciences.2018; 19(9): 2757.     CrossRef
  • Programming mediated by fatty acids affects uncoupling protein 1 (UCP-1) in brown adipose tissue
    Perla P. Argentato, Helena de Cássia César, Débora Estadella, Luciana P. Pisani
    British Journal of Nutrition.2018; 120(6): 619.     CrossRef
  • Effects of Genistein on Differentiation and Viability of Human Visceral Adipocytes
    Elena Grossini, Serena Farruggio, Giulia Raina, David Mary, Giacomo Deiro, Sergio Gentilli
    Nutrients.2018; 10(8): 978.     CrossRef
  • A comprehensive review of the health perspectives of resveratrol
    Abdur Rauf, Muhammad Imran, Hafiz Ansar Rasul Suleria, Bashir Ahmad, Dennis G. Peters, Mohammad S. Mubarak
    Food & Function.2017; 8(12): 4284.     CrossRef
  • The Role of Circulating Slit2, the One of the Newly Batokines, in Human Diabetes Mellitus
    Yea Eun Kang, Sorim Choung, Ju Hee Lee, Hyun Jin Kim, Bon Jeong Ku
    Endocrinology and Metabolism.2017; 32(3): 383.     CrossRef
  • A nutritional perspective on UCP1-dependent thermogenesis
    M. Luisa Bonet, Josep Mercader, Andreu Palou
    Biochimie.2017; 134: 99.     CrossRef
  • The Beneficial Effects of Quercetin, Curcumin, and Resveratrol in Obesity
    Yueshui Zhao, Bo Chen, Jing Shen, Lin Wan, Yinxin Zhu, Tao Yi, Zhangang Xiao
    Oxidative Medicine and Cellular Longevity.2017; 2017: 1.     CrossRef
  • Articles inEndocrinology and Metabolismin 2016
    Won-Young Lee
    Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
  • Antiobesity effects of resveratrol: which tissues are involved?
    Alfredo Fernández‐Quintela, Iñaki Milton‐Laskibar, Marcela González, Maria P. Portillo
    Annals of the New York Academy of Sciences.2017; 1403(1): 118.     CrossRef
  • Resveratrol attenuates triglyceride accumulation associated with upregulation of Sirt1 and lipoprotein lipase in 3T3-L1 adipocytes
    Haruki Imamura, Daiji Nagayama, Noriko Ishihara, Syo Tanaka, Rena Watanabe, Yasuhiro Watanabe, Yuta Sato, Takashi Yamaguchi, Noriko Ban, Hidetoshi Kawana, Masahiro Ohira, Kei Endo, Atsuhito Saiki, Kohji Shirai, Ichiro Tatsuno
    Molecular Genetics and Metabolism Reports.2017; 12: 44.     CrossRef
  • Resveratrol has dose-dependent effects on DNA fragmentation and mitochondrial activity of ovine secondary follicles cultured in vitro
    T.J.S. Macedo, V.R.P. Barros, A.P.O. Monte, B.B. Gouveia, M.É.S. Bezerra, A.Y.P. Cavalcante, R.S. Barberino, V.G. Menezes, M.H.T. Matos
    Zygote.2017; 25(4): 434.     CrossRef
  • Response: The Effects of High Fat Diet and Resveratrol on Mitochondrial Activity of Brown Adipocytes (Endocrinol Metab2016;31:328-35, Cheol Ryong Ku et al.)
    Cheol Ryong Ku, Eun Jig Lee
    Endocrinology and Metabolism.2016; 31(3): 482.     CrossRef
  • Letter: The Effects of High Fat Diet and Resveratrol on Mitochondrial Activity of Brown Adipocytes (Endocrinol Metab2016;31:328-35, Cheol Ryong Ku et al.)
    Ji-Young Cha
    Endocrinology and Metabolism.2016; 31(3): 480.     CrossRef
Close layer
Review Article
Mechanisms of Vascular Calcification: The Pivotal Role of Pyruvate Dehydrogenase Kinase 4
Jaechan Leem, In-Kyu Lee
Endocrinol Metab. 2016;31(1):52-61.   Published online March 16, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.1.52
  • 4,433 View
  • 69 Download
  • 30 Web of Science
  • 28 Crossref
AbstractAbstract PDFPubReader   

Vascular calcification, abnormal mineralization of the vessel wall, is frequently associated with aging, atherosclerosis, diabetes mellitus, and chronic kidney disease. Vascular calcification is a key risk factor for many adverse clinical outcomes, including ischemic cardiac events and subsequent cardiovascular mortality. Vascular calcification was long considered to be a passive degenerative process, but it is now recognized as an active and highly regulated process similar to bone formation. However, despite numerous studies on the pathogenesis of vascular calcification, the mechanisms driving this process remain poorly understood. Pyruvate dehydrogenase kinases (PDKs) play an important role in the regulation of cellular metabolism and mitochondrial function. Recent studies show that PDK4 is an attractive therapeutic target for the treatment of various metabolic diseases. In this review, we summarize our current knowledge regarding the mechanisms of vascular calcification and describe the role of PDK4 in the osteogenic differentiation of vascular smooth muscle cells and development of vascular calcification. Further studies aimed at understanding the molecular mechanisms of vascular calcification will be critical for the development of novel therapeutic strategies.

Citations

Citations to this article as recorded by  
  • Gamut of glycolytic enzymes in vascular smooth muscle cell proliferation: Implications for vascular proliferative diseases
    Ankan Sarkar, Sandip V. Pawar, Kanwaljit Chopra, Manish Jain
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2024; 1870(3): 167021.     CrossRef
  • MAPK14 as a key gene for regulating inflammatory response and macrophage M1 polarization induced by ferroptotic keratinocyte in psoriasis
    Lin Zhou, Yingdong Zhong, Chaowei Li, Yu Zhou, Xi Liu, Lincai Li, Zhengwei Zou, Zhihui Zhong, Junsong Ye
    Inflammation.2024;[Epub]     CrossRef
  • Pyruvate dehydrogenase kinase 4 promotes osteoblastic potential of BMP9 by boosting Wnt/β-catenin signaling in mesenchymal stem cells
    Yuan-Yuan Yang, Hong-Hong Luo, Yi-Xuan Deng, Xin-Tong Yao, Jie Zhang, Yu-Xi Su, Bai-Cheng He
    The International Journal of Biochemistry & Cell Biology.2023; 154: 106341.     CrossRef
  • lncRNA MEG3 Promotes PDK4/GSK-3β/β-Catenin Axis in MEFs by Targeting miR-532-5p
    Yuan-Yuan Yang, Yi-Xuan Deng, Xin-Tong Yao, Hong-Hong Luo, Wen-Ge He, Xuan-Ling Cao, Rong-Chun Chen, Bai-Cheng He, Hai-Tao Jiang, Jing Wang, Sedat Kacar
    Oxidative Medicine and Cellular Longevity.2023; 2023: 1.     CrossRef
  • Mitochondrial dynamics in vascular remodeling and target-organ damage
    Tong Zhu, Qingxun Hu, Yanggang Yuan, Huijuan Yao, Jian Zhang, Jia Qi
    Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
  • PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancy
    Xuefeng Dou, Qiang Fu, Qilai Long, Shuning Liu, Yejun Zou, Da Fu, Qixia Xu, Zhirui Jiang, Xiaohui Ren, Guilong Zhang, Xiaoling Wei, Qingfeng Li, Judith Campisi, Yuzheng Zhao, Yu Sun
    Nature Metabolism.2023; 5(11): 1887.     CrossRef
  • Identification of PDK4 as Hub Gene for Diabetic Nephropathy Using Co-Expression Network Analysis
    Yuanyuan Han, Liangzi Jin, Liangzhi Wang, Lan Wei, Chao Tu
    Kidney and Blood Pressure Research.2023; 48(1): 522.     CrossRef
  • Flavocoxid Ameliorates Aortic Calcification Induced by Hypervitaminosis D3 and Nicotine in Rats Via Targeting TNF-α, IL-1β, iNOS, and Osteogenic Runx2
    Ahmed E. Amer, George S. G. Shehatou, Hassan A. El-Kashef, Manar A. Nader, Ahmed R. El-Sheakh
    Cardiovascular Drugs and Therapy.2022; 36(6): 1047.     CrossRef
  • Diabetic mellitus, vascular calcification and hypoxia: A complex and neglected tripartite relationship
    Xue-Jiao Sun, Nai-Feng Liu
    Cellular Signalling.2022; 91: 110219.     CrossRef
  • Insights Into the Role of Mitochondria in Vascular Calcification
    ZL Zeng, Qing Yuan, Xuyu Zu, Jianghua Liu
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • Induced pluripotent stem cell-derived smooth muscle cells to study cardiovascular calcification
    Samantha K. Atkins, Abhijeet R. Sonawane, Romi Brouwhuis, Johana Barrientos, Anna Ha, Maximillian Rogers, Takeshi Tanaka, Takehito Okui, Shiori Kuraoka, Sasha A. Singh, Masanori Aikawa, Elena Aikawa
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • Phenotypic plasticity of vascular smooth muscle cells in vascular calcification: Role of mitochondria
    Yan Zhong Liu, Zong Xiang Li, Lin Lin Zhang, Dan Wang, Yi Ping Liu
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • Febuxostat attenuates vascular calcification induced by vitamin D3 plus nicotine in rats
    Ahmed E. Amer, Ahmed R. El-Sheakh, Mohamed F. Hamed, Hassan A. El-Kashef, Manar A. Nader, George S.G. Shehatou
    European Journal of Pharmaceutical Sciences.2021; 156: 105580.     CrossRef
  • Mitochondria and traffic-related air pollution linked coronary artery calcification: exploring the missing link
    Bhavana Sivakumar, Gino A. Kurian
    Reviews on Environmental Health.2021; 36(4): 545.     CrossRef
  • Mitochondria Homeostasis and Vascular Medial Calcification
    Min li, Yi Zhu, Sandip Kumar Jaiswal, Nai-Feng Liu
    Calcified Tissue International.2021; 109(2): 113.     CrossRef
  • POSTN promotes diabetic vascular calcification by interfering with autophagic flux
    Xue-Jiao Sun, Wen-Qi Ma, Yi Zhu, Nai-Feng Liu
    Cellular Signalling.2021; 83: 109983.     CrossRef
  • The MAMs Structure and Its Role in Cell Death
    Nan Wang, Chong Wang, Hongyang Zhao, Yichun He, Beiwu Lan, Liankun Sun, Yufei Gao
    Cells.2021; 10(3): 657.     CrossRef
  • Pyruvate dehydrogenase kinases (PDKs): an overview toward clinical applications
    Xiuxiu Wang, Xiaoyue Shen, Yuting Yan, Hongmin Li
    Bioscience Reports.2021;[Epub]     CrossRef
  • Label-Free Multiphoton Microscopy for the Detection and Monitoring of Calcific Aortic Valve Disease
    Ishita Tandon, Kyle P. Quinn, Kartik Balachandran
    Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
  • Vascular Calcification—New Insights into Its Mechanism
    Sun Joo Lee, In-Kyu Lee, Jae-Han Jeon
    International Journal of Molecular Sciences.2020; 21(8): 2685.     CrossRef
  • Osteocalcin Regulates Arterial Calcification Via Altered Wnt Signaling and Glucose Metabolism
    Nabil A Rashdan, Alisia M Sim, Lin Cui, Kanchan Phadwal, Fiona L Roberts, Roderick Carter, Derya D Ozdemir, Peter Hohenstein, John Hung, Jakub Kaczynski, David E Newby, Andrew H Baker, Gerard Karsenty, Nicholas M Morton, Vicky E MacRae
    Journal of Bone and Mineral Research.2020; 35(2): 357.     CrossRef
  • The role of mitochondria in vascular calcification
    Pengbo Wang, Naijin Zhang, Boquan Wu, Shaojun Wu, Ying Zhang, Yingxian Sun
    Journal of Translational Internal Medicine.2020; 8(2): 80.     CrossRef
  • Cerebral blood flow in dystonia due to pantothenate kinase-associated neurodegeneration
    Peter Stoeter, Pedro Roa-Sanchez, Cesar F Gonzalez, Herwin Speckter, Jairo Oviedo, Pamela Bido
    The Neuroradiology Journal.2020; 33(6): 479.     CrossRef
  • PDK4 promotes vascular calcification by interfering with autophagic activity and metabolic reprogramming
    Wen-Qi Ma, Xue-Jiao Sun, Yi Zhu, Nai-Feng Liu
    Cell Death & Disease.2020;[Epub]     CrossRef
  • Restoring mitochondrial biogenesis with metformin attenuates β-GP-induced phenotypic transformation of VSMCs into an osteogenic phenotype via inhibition of PDK4/oxidative stress-mediated apoptosis
    Wen-Qi Ma, Xue-Jiao Sun, Ying Wang, Yi Zhu, Xi-Qiong Han, Nai-Feng Liu
    Molecular and Cellular Endocrinology.2019; 479: 39.     CrossRef
  • Salusin-β Promotes Vascular Calcification via Nicotinamide Adenine Dinucleotide Phosphate/Reactive Oxygen Species-Mediated Klotho Downregulation
    Haijian Sun, Feng Zhang, Yu Xu, Shuo Sun, Huiping Wang, Qiong Du, Chenxin Gu, Stephen M. Black, Ying Han, Haiyang Tang
    Antioxidants & Redox Signaling.2019; 31(18): 1352.     CrossRef
  • Fibroblast Growth Factor 21 (FGF21) Promotes Formation of Aerobic Myofibers via the FGF21‐SIRT1‐AMPK‐PGC1α Pathway
    Xinyi Liu, Yongliang Wang, Liming Hou, Yuanzhu Xiong, Shuhong Zhao
    Journal of Cellular Physiology.2017; 232(7): 1893.     CrossRef
  • Articles inEndocrinology and Metabolismin 2016
    Won-Young Lee
    Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
Close layer
Original Articles
Endocrine Research
Selective Mitochondrial Uptake of MKT-077 Can Suppress Medullary Thyroid Carcinoma Cell Survival In Vitro and In Vivo
Dmytro Starenki, Jong-In Park
Endocrinol Metab. 2015;30(4):593-603.   Published online December 31, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.4.593
  • 3,894 View
  • 39 Download
  • 16 Web of Science
  • 15 Crossref
AbstractAbstract PDFPubReader   
Background

Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor mainly caused by mutations in the rearranged during transfection (RET) proto-oncogene. Not all patients with progressive MTC respond to current therapy inhibiting RET, demanding additional therapeutic strategies. We recently demonstrated that disrupting mitochondrial metabolism using a mitochondria-targeted agent or by depleting a mitochondrial chaperone effectively suppressed human MTC cells in culture and in mouse xenografts by inducing apoptosis and RET downregulation. These observations led us to hypothesize that mitochondria are potential therapeutic targets for MTC. This study further tests this hypothesis using1-ethyl-2-[[3-ethyl-5-(3-methylbenzothiazolin-2-yliden)]-4-oxothiazolidin-2-ylidenemethyl] pyridinium chloride (MKT-077), a water-soluble rhodocyanine dye analogue, which can selectively accumulate in mitochondria.

Methods

The effects of MKT-077 on cell proliferation, survival, expression of RET and tumor protein 53 (TP53), and mitochondrial activity were determined in the human MTC lines in culture and in mouse xenografts.

Results

MKT-077 induced cell cycle arrest in TT and MZ-CRC-1. Intriguingly, MKT-077 also induced RET downregulation and strong cell death responses in TT cells, but not in MZ-CRC-1 cells. This discrepancy was mainly due to the difference between the capacities of these cell lines to retain MKT-077 in mitochondria. The cytotoxicity of MKT-077 in TT cells was mainly attributed to oxidative stress while being independent of TP53. MKT-077 also effectively suppressed tumor growth of TT xenografts.

Conclusion

MKT-077 can suppress cell survival of certain MTC subtypes by accumulating in mitochondria and interfering with mitochondrial activity although it can also suppress cell proliferation via other mechanisms. These results consistently support the hypothesis that mitochondrial targeting has therapeutic potential for MTC.

Citations

Citations to this article as recorded by  
  • Immunoexpression of HSPA9 and CUL2 in prostatic tissue and adenocarcinoma
    Carlos Gustavo Hirth, Gislane Rocha Vasconcelos, Maria do Perpétuo Socorro Saldanha da Cunha, Carlos Heli Bezerra Leite, Conceição Aparecida Dornelas
    Annals of Diagnostic Pathology.2022; 56: 151843.     CrossRef
  • Analogs of the Heat Shock Protein 70 Inhibitor MKT-077 Suppress Medullary Thyroid Carcinoma Cells
    Seung-Keun Hong, Dmytro Starenki, Oleta T. Johnson, Jason E. Gestwicki, Jong-In Park
    International Journal of Molecular Sciences.2022; 23(3): 1063.     CrossRef
  • Effect of F16-Betulin Conjugate on Mitochondrial Membranes and Its Role in Cell Death Initiation
    Mikhail V. Dubinin, Alena A. Semenova, Darya A. Nedopekina, Eldar V. Davletshin, Anna Yu. Spivak, Konstantin N. Belosludtsev
    Membranes.2021; 11(5): 352.     CrossRef
  • A BAG's life: Every connection matters in cancer
    Elena Mariotto, Giampietro Viola, Carlo Zanon, Sanja Aveic
    Pharmacology & Therapeutics.2020; 209: 107498.     CrossRef
  • Emerging insights into mitochondria-specific targeting and drug delivering strategies: Recent milestones and therapeutic implications
    Sugapriya Dhanasekaran, Divya Venugopal, Noura Al-Dayan, Vijaya Ravinayagam, Arif Ahmed Mohammed
    Saudi Journal of Biological Sciences.2020; 27(12): 3581.     CrossRef
  • Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway
    Pui-Kei Wu, Andrew Becker, Jong-In Park
    International Journal of Molecular Sciences.2020; 21(15): 5436.     CrossRef
  • Heat Shock Proteins (HSPs): A Novel Target for Cancer Metastasis Prevention
    Vinayak Narayanankutty , Arunaksharan Narayanankutty, Anusree Nair
    Current Drug Targets.2019; 20(7): 727.     CrossRef
  • Токсичність МАРК у карциномах щитоподібної залози. Механізми пригнічення сигнального каскаду (огляд літератури та власних даних)
    B. B. Guda, V. V. Pushkarev, O. I. Kovzun, V. P. Pushkarev, M. D. Tronko
    Шпитальна хірургія. Журнал імені Л. Я. Ковальчука.2019; (3): 84.     CrossRef
  • Mortalin (GRP75/HSPA9) Promotes Survival and Proliferation of Thyroid Carcinoma Cells
    Dmytro Starenki, Nadiya Sosonkina, Seung-Keun Hong, Ricardo V. Lloyd, Jong-In Park
    International Journal of Molecular Sciences.2019; 20(9): 2069.     CrossRef
  • Mitochondrial autophagosomes as a mechanism of drug resistance in breast carcinoma
    Ayman N. Abunimer, Heba Mohammed, Katherine L. Cook, David R. Soto-Pantoja, Maria Mercedes Campos, Mones S. Abu-Asab
    Ultrastructural Pathology.2018; 42(2): 170.     CrossRef
  • Genotoxic Responses of Mitochondrial Oxygen Consumption Rate and Mitochondrial Semiquinone Radicals in Tumor Cells
    Kumiko Yamamoto, Hironobu Yasui, Tomoki Bo, Tohru Yamamori, Wakako Hiraoka, Toshihide Yamasaki, Ken-ichi Yamada, Osamu Inanami
    Applied Magnetic Resonance.2018; 49(8): 837.     CrossRef
  • Suppression of B-RafV600E melanoma cell survival by targeting mitochondria using triphenyl-phosphonium-conjugated nitroxide or ubiquinone
    Seung-Keun Hong, Dmytro Starenki, Pui-Kei Wu, Jong-In Park
    Cancer Biology & Therapy.2017; 18(2): 106.     CrossRef
  • Mitochondria chaperone GRP75 moonlighting as a cell cycle controller to derail endocytosis provides an opportunity for nanomicrosphere intracellular delivery
    Zhihui Gao, Xiuran Niu, Qing Zhang, Hang Chen, Aiai Gao, Shanshan Qi, Rong Xiang, Mattias Belting, Sihe Zhang
    Oncotarget.2017; 8(35): 58536.     CrossRef
  • Targeted Therapy for Medullary Thyroid Cancer: A Review
    S. R. Priya, Chandra Shekhar Dravid, Raghunadharao Digumarti, Mitali Dandekar
    Frontiers in Oncology.2017;[Epub]     CrossRef
  • Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells
    Dmytro Starenki, Seung-Keun Hong, Pui-Kei Wu, Jong-In Park
    Cancer Biology & Therapy.2017; 18(7): 473.     CrossRef
Close layer
Endocrine Research
Diastolic Dysfunction Induced by a High-Fat Diet Is Associated with Mitochondrial Abnormality and Adenosine Triphosphate Levels in Rats
Ki-Woon Kang, Ok-Soon Kim, Jung Yeon Chin, Won Ho Kim, Sang Hyun Park, Yu Jeong Choi, Jong Ho Shin, Kyung Tae Jung, Do-Seon Lim, Seong-Kyu Lee
Endocrinol Metab. 2015;30(4):557-568.   Published online December 31, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.4.557
  • 4,879 View
  • 46 Download
  • 13 Web of Science
  • 13 Crossref
AbstractAbstract PDFPubReader   
Background

Obesity is well-known as a risk factor for heart failure, including diastolic dysfunction. However, this mechanism in high-fat diet (HFD)-induced obese rats remain controversial. The purpose of this study was to investigate whether cardiac dysfunction develops when rats are fed with a HFD for 10 weeks; additionally, we sought to investigate the association between mitochondrial abnormalities, adenosine triphosphate (ATP) levels and cardiac dysfunction.

Methods

We examined myocardia in Wistar rats after 10 weeks of HFD (45 kcal% fat, n=6) or standard diet (SD, n=6). Echocardiography, histomorphologic analysis, and electron microscopy were performed. The expression levels of mitochondrial oxidative phosphorylation (OXPHOS) subunit genes, peroxisome-proliferator-activated receptor γ co-activator-1α (PGC1α) and anti-oxidant enzymes were assessed. Markers of oxidative stress damage, mitochondrial DNA copy number and myocardial ATP level were also examined.

Results

After 10 weeks, the body weight of the HFD group (349.6±22.7 g) was significantly higher than that of the SD group (286.8±14.9 g), and the perigonadal and epicardial fat weights of the HFD group were significantly higher than that of the SD group. Histomorphologic and electron microscopic images were similar between the two groups. However, in the myocardium of the HFD group, the expression levels of OXPHOS subunit NDUFB5 in complex I and PGC1α, and the mitochondrial DNA copy number were decreased and the oxidative stress damage marker 8-hydroxydeoxyguanosine was increased, accompanied by reduced ATP levels.

Conclusion

Diastolic dysfunction was accompanied by the mitochondrial abnormality and reduced ATP levels in the myocardium of 10 weeks-HFD-induced rats.

Citations

Citations to this article as recorded by  
  • Epicardial Adipose Tissue in Myocardial Disease: From Physiology to Heart Failure Phenotypes
    Alexios S. Antonopoulos, Charalampos Papastamos, Dennis V. Cokkinos, Konstantinos Tsioufis, Dimitris Tousoulis
    Current Problems in Cardiology.2023; 48(10): 101841.     CrossRef
  • Metabolic mitochondrial alterations prevail in the female rat heart 8 weeks after exercise cessation
    Carolina Tocantins, João D. Martins, Óscar M. Rodrigues, Luís F. Grilo, Mariana S. Diniz, Jelena Stevanovic‐Silva, Jorge Beleza, Pedro Coxito, David Rizo‐Roca, Estela Santos‐Alves, Manoel Rios, Lina Carvalho, António J. Moreno, António Ascensão, José Maga
    European Journal of Clinical Investigation.2023;[Epub]     CrossRef
  • The link between obesity and aging - insights into cardiac energy metabolism
    Patricia Owesny, Tilman Grune
    Mechanisms of Ageing and Development.2023; 216: 111870.     CrossRef
  • Surgically Metabolic Resection of Pericardial Fat to Ameliorate Myocardial Mitochondrial Dysfunction in Acute Myocardial Infarction Obese Rats
    Ki-Woon Kang, Ju-Young Ko, Hyunghee Lee, Seung Yong Shin, Wang Soo Lee, Joonhwa Hong, Sang-Wook Kim, Seong-Kyu Lee, Min-Ho Oak
    Journal of Korean Medical Science.2022;[Epub]     CrossRef
  • Cilostazol attenuates cardiac oxidative stress and inflammation in hypercholesterolemic rats
    Rosane de Oliveira Lopes, Gabriel Ferreira Lima, Ana Beatriz Araújo Mendes, Lis Jappour Autran, Nikolas Cunha de Assis Pereira, Stephani Correia Brazão, Beatriz Alexandre-Santos, Eliete Dalla Corte Frantz, Christianne Brêtas Vieira Scaramello, Fernanda Ca
    Naunyn-Schmiedeberg's Archives of Pharmacology.2022; 395(7): 789.     CrossRef
  • The impact of diet upon mitochondrial physiology (Review)
    Ioannis Kyriazis, Eleni Vassi, Maria Alvanou, Christos Angelakis, Zoi Skaperda, Fotios Tekos, Venkata Garikipati, Demetrios Spandidos, Demetrios Kouretas
    International Journal of Molecular Medicine.2022;[Epub]     CrossRef
  • SIRT1 promotes lipid metabolism and mitochondrial biogenesis in adipocytes and coordinates adipogenesis by targeting key enzymatic pathways
    Yasser Majeed, Najeeb Halabi, Aisha Y. Madani, Rudolf Engelke, Aditya M. Bhagwat, Houari Abdesselem, Maha V. Agha, Muneera Vakayil, Raphael Courjaret, Neha Goswami, Hisham Ben Hamidane, Mohamed A. Elrayess, Arash Rafii, Johannes Graumann, Frank Schmidt, N
    Scientific Reports.2021;[Epub]     CrossRef
  • Physical Exercise Potentially Targets Epicardial Adipose Tissue to Reduce Cardiovascular Disease Risk in Patients with Metabolic Diseases: Oxidative Stress and Inflammation Emerge as Major Therapeutic Targets
    Thembeka A. Nyawo, Carmen Pheiffer, Sithandiwe E. Mazibuko-Mbeje, Sinenhlanhla X. H. Mthembu, Tawanda M. Nyambuya, Bongani B. Nkambule, Hanél Sadie-Van Gijsen, Hans Strijdom, Luca Tiano, Phiwayinkosi V. Dludla
    Antioxidants.2021; 10(11): 1758.     CrossRef
  • Potentially Critical Roles ofNDUFB5,TIMMDC1,and VDAC3in the Progression of Septic Cardiomyopathy Through Integrated Bioinformatics Analysis
    Kai Kang, Jingtian Li, Ruidong Li, Xiufeng Xu, Jianli Liu, Limin Qin, Tao Huang, Jinhua Wu, Min Jiao, Miaomiao Wei, Hongjie Wang, Tao Wang, Quan Zhang
    DNA and Cell Biology.2020; 39(1): 105.     CrossRef
  • Liraglutide shows superior cardiometabolic benefits than lorcaserin in a novel free choice diet-induced obese rat model
    François Briand, Emmanuel Brousseau, Julie Maupoint, Caroline Dubroca, Clément Costard, Natalia Breyner, Rémy Burcelin, Thierry Sulpice
    European Journal of Pharmacology.2020; 882: 173316.     CrossRef
  • Mitochondrial impairment following neonatal overfeeding: A comparison between normal and ischemic‐reperfused hearts
    Cristiane de Moura Freitas, Luciana Caroline Paulino do Nascimento, Glauber Rudá Feitoza Braz, Severina Cassia Andrade‐Silva, Nelson C. Lima‐Junior, Tercya de Araujo Silva, Mariana Pinheiro Fernandes, Diorginis José Soares Ferreira, Claudia Jacques Lagran
    Journal of Cellular Biochemistry.2019; 120(5): 7341.     CrossRef
  • Exercise training reverses age‐induced diastolic dysfunction and restores coronary microvascular function
    Kazuki Hotta, Bei Chen, Bradley J. Behnke, Payal Ghosh, John N. Stabley, Jeremy A. Bramy, Jaime L. Sepulveda, Michael D. Delp, Judy M. Muller‐Delp
    The Journal of Physiology.2017; 595(12): 3703.     CrossRef
  • Qiliqiangxin Enhances Cardiac Glucose Metabolism and Improves Diastolic Function in Spontaneously Hypertensive Rats
    Jingfeng Wang, Zhiming Li, Yanyan Wang, Jingjing Zhang, Weipeng Zhao, Mingqiang Fu, Xueting Han, Jingmin Zhou, Junbo Ge
    Evidence-Based Complementary and Alternative Medicine.2017; 2017: 1.     CrossRef
Close layer
Brief Report
Obesity and Metabolism
Glucagon-Like Peptide-1 Increases Mitochondrial Biogenesis and Function in INS-1 Rat Insulinoma Cells
Mi Yeon Kang, Tae Jung Oh, Young Min Cho
Endocrinol Metab. 2015;30(2):216-220.   Published online June 30, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.2.216
  • 4,003 View
  • 44 Download
  • 41 Web of Science
  • 40 Crossref
AbstractAbstract PDFPubReader   

Glucagon-like peptide-1 (GLP-1) is a gut-derived incretin hormone that increases glucose-stimulated insulin secretion in pancreatic β-cells. Since mitochondrial function is crucial to insulin secretion, we hypothesized that GLP-1 may increase mitochondrial biogenesis in pancreatic β-cells. We treated INS-1 rat insulinoma cells with GLP-1 or exendin-4 for 48 hours and measured mitochondrial mass and function. Both GLP-1 and exendin-4 increased mitochondrial mass by approximately 20%. The mitochondria/cytosol ratio was increased from 7.60±3.12% to 10.53±2.70% by exendin-4. In addition, GLP-1 increased the mitochondrial membrane potential and oxygen consumption. Proliferator-activated receptor-gamma coactivator 1α expression was increased approximately 2-fold by GLP-1 treatment. In conclusion, the present study presents evidence for a new mechanism of action by which GLP-1 improves pancreatic β-cell function via enhanced mitochondrial mass and performance.

Citations

Citations to this article as recorded by  
  • New fraternine analogues: Evaluation of the antiparkinsonian effect in the model of Parkinson's disease
    Andréia Biolchi Mayer, Henrique de Oliveira Amaral, Danilo Gustavo R. de Oliveira, Gabriel Avohay Alves Campos, Priscilla Galante Ribeiro, Solange Cristina Rego Fernandes, Adolfo Carlos Barros de Souza, Raffael Júnio Araújo de Castro, Anamélia Lorenzetti
    Neuropeptides.2024; 103: 102390.     CrossRef
  • Prospects of antidiabetic drugs in the treatment of neurodegenerative disease
    Lidan Hu, Wenmin Wang, Xiangjun Chen, Guannan Bai, Liangjian Ma, Xin Yang, Qiang Shu, Xuekun Li
    Brain‐X.2024;[Epub]     CrossRef
  • Attenuating mitochondrial dysfunction and morphological disruption with PT320 delays dopamine degeneration in MitoPark mice
    Vicki Wang, Kuan-Yin Tseng, Tung-Tai Kuo, Eagle Yi-Kung Huang, Kuo-Lun Lan, Zi-Rong Chen, Kuo-Hsing Ma, Nigel H. Greig, Jin Jung, Ho-II Choi, Lars Olson, Barry J. Hoffer, Yuan-Hao Chen
    Journal of Biomedical Science.2024;[Epub]     CrossRef
  • Liraglutide demonstrates a therapeutic effect on mitochondrial dysfunction in human SGBS adipocytes in vitro
    Maija Vaittinen, Mariana Ilha, Elena Herbers, Anita Wagner, Kirsi A. Virtanen, Kirsi H. Pietiläinen, Eija Pirinen, Jussi Pihlajamäki
    Diabetes Research and Clinical Practice.2023; 199: 110635.     CrossRef
  • The cardioprotective effect of human glucagon‐like peptide‐1 receptor agonist (semaglutide) on cisplatin‐induced cardiotoxicity in rats: Targeting mitochondrial functions, dynamics, biogenesis, and redox status pathways
    Marwa Mohamed Atef, Yasser Mostafa Hafez, Omnia Safwat El‐Deeb, Eman H. Basha, Radwa Ismail, Hanan Alshenawy, Rasha Osama El‐Esawy, Amira Kamel Eltokhy
    Cell Biochemistry and Function.2023; 41(4): 450.     CrossRef
  • Targeting mitochondrial quality control for diabetic cardiomyopathy: Therapeutic potential of hypoglycemic drugs
    Yutong Zhou, Wendong Suo, Xinai Zhang, Jiaojiao Liang, Weizhe Zhao, Yue Wang, Hong Li, Qing Ni
    Biomedicine & Pharmacotherapy.2023; 168: 115669.     CrossRef
  • Soft X-ray tomography to map and quantify organelle interactions at the mesoscale
    Valentina Loconte, Jitin Singla, Angdi Li, Jian-Hua Chen, Axel Ekman, Gerry McDermott, Andrej Sali, Mark Le Gros, Kate L. White, Carolyn A. Larabell
    Structure.2022; 30(4): 510.     CrossRef
  • Comparisons of pleiotropic effects of SGLT2 inhibition and GLP-1 agonism on cardiac glucose intolerance in heart dysfunction
    Belma Turan, Aysegul Durak, Yusuf Olgar, Erkan Tuncay
    Molecular and Cellular Biochemistry.2022; 477(11): 2609.     CrossRef
  • Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs
    Carolin Thomas, Lia Wurzer, Ernst Malle, Michael Ristow, Corina T. Madreiter-Sokolowski
    Frontiers in Aging.2022;[Epub]     CrossRef
  • Anti-cancer effects of sitagliptin, vildagliptin, and exendin-4 on triple-negative breast cancer cells via mitochondrial modulation
    POOJA JAISWAL, VERSHA TRIPATHI, ANSHUL ASSAIYA, DHARMENDRA KASHYAP, RAHUL DUBEY, ANAMIKA SINGH, JANESH KUMAR, HEM CHANDRA JHA, RAJESH SHARMA, AMIT KUMAR DIXIT, HAMENDRA SINGH PARMAR
    BIOCELL.2022; 46(12): 2645.     CrossRef
  • Effect of liraglutide on neural and peripheral markers of metabolic function during antipsychotic treatment in rats
    Ilijana Babic, Dominic Sellers, Paul L Else, Jessica Nealon, Ashleigh L Osborne, Nagesh Pai, Katrina Weston-Green
    Journal of Psychopharmacology.2021; 35(3): 284.     CrossRef
  • Sustained Release GLP-1 Agonist PT320 Delays Disease Progression in a Mouse Model of Parkinson’s Disease
    Vicki Wang, Tung-Tai Kuo, Eagle Yi-Kung Huang, Kuo-Hsing Ma, Yu-Ching Chou, Zhao-Yang Fu, Li-Wen Lai, Jin Jung, Hoi-II Choi, Doo-Sup Choi, Yazhou Li, Lars Olson, Nigel H. Greig, Barry J. Hoffer, Yuan-Hao Chen
    ACS Pharmacology & Translational Science.2021; 4(2): 858.     CrossRef
  • Antioxidative Potentials of Incretin-Based Medications: A Review of Molecular Mechanisms
    Habib Yaribeygi, Mina Maleki, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar, Marina Sokovi
    Oxidative Medicine and Cellular Longevity.2021; 2021: 1.     CrossRef
  • Vernicia fordii (Hemsl.) Airy Shaw extract stimulates insulin secretion in pancreatic β-cells and improves insulin sensitivity in diabetic mice
    Jimin Hyun, Mi Hyeon Park, Yo Han Lee, Youngeun Lee, Su Ji Jeong, Sun Sil Choi, Keon Woo Khim, Hye Jin Eom, Jin-Hoe Hur, Chan Young Park, Jae-Ick Kim, Jiyoung Park, Hyung Won Ryu, Hyun-Jun Jang, Sei-Ryang Oh, Jang Hyun Choi
    Journal of Ethnopharmacology.2021; 278: 114238.     CrossRef
  • Connecting the dots between mitochondrial dysfunction and Parkinson’s disorder: focus mitochondria-targeting therapeutic paradigm in mitigating the disease severity
    Ishnoor Kaur, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Lotfi Aleya, Simona Bungau
    Environmental Science and Pollution Research.2021; 28(28): 37060.     CrossRef
  • Neuromodulatory effects of anti-diabetes medications: A mechanistic review
    Habib Yaribeygi, Milad Ashrafizadeh, Neil C. Henney, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar
    Pharmacological Research.2020; 152: 104611.     CrossRef
  • Antidiabetic Agents for Treatment of Parkinson’s Disease: A Meta-Analysis
    Shu-Yi Wang, Shey-Lin Wu, Ta-Cheng Chen, Chieh-Sen Chuang
    International Journal of Environmental Research and Public Health.2020; 17(13): 4805.     CrossRef
  • Visualizing subcellular rearrangements in intact β cells using soft x-ray tomography
    Kate L. White, Jitin Singla, Valentina Loconte, Jian-Hua Chen, Axel Ekman, Liping Sun, Xianjun Zhang, John Paul Francis, Angdi Li, Wen Lin, Kaylee Tseng, Gerry McDermott, Frank Alber, Andrej Sali, Carolyn Larabell, Raymond C. Stevens
    Science Advances.2020;[Epub]     CrossRef
  • Nutrient Sensor mTOR and OGT: Orchestrators of Organelle Homeostasis in Pancreatic β-Cells
    Nicholas Esch, Seokwon Jo, Mackenzie Moore, Emilyn U. Alejandro, Yingke Xu
    Journal of Diabetes Research.2020; 2020: 1.     CrossRef
  • Metabolic dynamics of human Sertoli cells are differentially modulated by physiological and pharmacological concentrations of GLP-1
    Ana D. Martins, Mariana P. Monteiro, Branca M. Silva, Alberto Barros, Mário Sousa, Rui A. Carvalho, Pedro F. Oliveira, Marco G. Alves
    Toxicology and Applied Pharmacology.2019; 362: 1.     CrossRef
  • Sarcopenia in Chronic Kidney Disease: Factors, Mechanisms, and Therapeutic Interventions
    Hiroshi Watanabe, Yuki Enoki, Toru Maruyama
    Biological and Pharmaceutical Bulletin.2019; 42(9): 1437.     CrossRef
  • Recent Advances in Drug Repurposing for Parkinson’s Disease
    Xin Chen, Giuseppe Gumina, Kristopher G. Virga
    Current Medicinal Chemistry.2019; 26(28): 5340.     CrossRef
  • Mitochondrial dysfunction in diabetes and the regulatory roles of antidiabetic agents on the mitochondrial function
    Habib Yaribeygi, Stephen L. Atkin, Amirhossein Sahebkar
    Journal of Cellular Physiology.2019; 234(6): 8402.     CrossRef
  • Liraglutide protects against glucolipotoxicity‐induced RIN‐m5F β‐cell apoptosis through restoration of PDX1 expression
    Edy Kornelius, Hsin‐Hua Li, Chiung‐Huei Peng, Yi‐Sun Yang, Wei‐Jen Chen, Yan‐Zin Chang, Yi‐Chiao Bai, Stanley Liu, Chien‐Ning Huang, Chih‐Li Lin
    Journal of Cellular and Molecular Medicine.2019; 23(1): 619.     CrossRef
  • The osteogenic effect of liraglutide involves enhanced mitochondrial biogenesis in osteoblasts
    Subhashis Pal, Shailendra K. Maurya, Sourav Chattopadhyay, Shyamsundar Pal China, Konica Porwal, Chirag Kulkarni, Sabyasachi Sanyal, Rohit A. Sinha, Naibedya Chattopadhyay
    Biochemical Pharmacology.2019; 164: 34.     CrossRef
  • Novel Treatment Opportunities Against Cognitive Impairment in Parkinson’s Disease with an Emphasis on Diabetes-Related Pathways
    Holly Green, Panagiota Tsitsi, Ioanna Markaki, Dag Aarsland, Per Svenningsson
    CNS Drugs.2019; 33(2): 143.     CrossRef
  • Mitral cells and the glucagon‐like peptide 1 receptor: The sweet smell of success?
    Enrico Bagnoli, Una FitzGerald
    European Journal of Neuroscience.2019; 49(4): 422.     CrossRef
  • Targeting the DPP-4-GLP-1 pathway improves exercise tolerance in heart failure patients: a systematic review and meta-analysis
    Chengcong Chen, Ying Huang, Yongmei Zeng, Xiyan Lu, Guoqing Dong
    BMC Cardiovascular Disorders.2019;[Epub]     CrossRef
  • Acute exposure to 3‑deoxyglucosone at high glucose levels impairs insulin secretion from β‑cells by downregulating the sweet taste receptor signaling pathway
    Xiudao Song, Guoqiang Liang, Min Shi, Liang Zhou, Fei Wang, Lurong Zhang, Fei Huang, Guorong Jiang
    Molecular Medicine Reports.2019;[Epub]     CrossRef
  • Translational approaches to restoring mitochondrial function in Parkinson's disease
    Heather Mortiboys, Ruby Macdonald, Thomas Payne, Matilde Sassani, Thomas Jenkins, Oliver Bandmann
    FEBS Letters.2018; 592(5): 776.     CrossRef
  • Neuroprotective exendin-4 enhances hypothermia therapy in a model of hypoxic-ischaemic encephalopathy
    Eridan Rocha-Ferreira, Laura Poupon, Aura Zelco, Anna-Lena Leverin, Syam Nair, Andrea Jonsdotter, Ylva Carlsson, Claire Thornton, Henrik Hagberg, Ahad A Rahim
    Brain.2018; 141(10): 2925.     CrossRef
  • Current perspective of mitochondrial biology in Parkinson's disease
    Navneet Ammal Kaidery, Bobby Thomas
    Neurochemistry International.2018; 117: 91.     CrossRef
  • Humanin promotes mitochondrial biogenesis in pancreatic MIN6 β-cells
    Qingqing Qin, Jieqiong Jin, Fang He, Yongqin Zheng, Tingting Li, Yun Zhang, Jundong He
    Biochemical and Biophysical Research Communications.2018; 497(1): 292.     CrossRef
  • Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
    Dilan Athauda, Kate Maclagan, Simon S Skene, Martha Bajwa-Joseph, Dawn Letchford, Kashfia Chowdhury, Steve Hibbert, Natalia Budnik, Luca Zampedri, John Dickson, Yazhou Li, Iciar Aviles-Olmos, Thomas T Warner, Patricia Limousin, Andrew J Lees, Nigel H Grei
    The Lancet.2017; 390(10103): 1664.     CrossRef
  • Alogliptin, a Dipeptidyl Peptidase‐4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits
    Xiaowei Zhang, Zhiwei Zhang, Yungang Zhao, Ning Jiang, Jiuchun Qiu, Yajuan Yang, Jian Li, Xue Liang, Xinghua Wang, Gary Tse, Guangping Li, Tong Liu
    Journal of the American Heart Association.2017;[Epub]     CrossRef
  • Potential therapeutic interventions for chronic kidney disease‐associated sarcopenia via indoxyl sulfate‐induced mitochondrial dysfunction
    Yuki Enoki, Hiroshi Watanabe, Riho Arake, Rui Fujimura, Kana Ishiodori, Tadashi Imafuku, Kento Nishida, Ryusei Sugimoto, Saori Nagao, Shigeyuki Miyamura, Yu Ishima, Motoko Tanaka, Kazutaka Matsushita, Hirotaka Komaba, Masafumi Fukagawa, Masaki Otagiri, To
    Journal of Cachexia, Sarcopenia and Muscle.2017; 8(5): 735.     CrossRef
  • The pancreas: Bandmaster of glucose homeostasis
    Nathalie Jouvet, Jennifer L. Estall
    Experimental Cell Research.2017; 360(1): 19.     CrossRef
  • The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action
    Dilan Athauda, Thomas Foltynie
    Drug Discovery Today.2016; 21(5): 802.     CrossRef
  • Effects of addition of a dipeptidyl peptidase IV inhibitor to metformin on sirolimus-induced diabetes mellitus
    Long Jin, Sun Woo Lim, Jian Jin, Byung Ha Chung, Chul Woo Yang
    Translational Research.2016; 174: 122.     CrossRef
  • Pharmacological Modulators of Endoplasmic Reticulum Stress in Metabolic Diseases
    Tae Jung, Kyung Choi
    International Journal of Molecular Sciences.2016; 17(2): 192.     CrossRef
Close layer
Review Article
Thyroid
Mitochondrial Energy Metabolism and Thyroid Cancers
Junguee Lee, Joon Young Chang, Yea Eun Kang, Shinae Yi, Min Hee Lee, Kyong Hye Joung, Kun Soon Kim, Minho Shong
Endocrinol Metab. 2015;30(2):117-123.   Published online June 30, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.2.117
  • 4,308 View
  • 50 Download
  • 15 Web of Science
  • 16 Crossref
AbstractAbstract PDFPubReader   

Primary thyroid cancers including papillary, follicular, poorly differentiated, and anaplastic carcinomas show substantial differences in biological and clinical behaviors. Even in the same pathological type, there is wide variability in the clinical course of disease progression. The molecular carcinogenesis of thyroid cancer has advanced tremendously in the last decade. However, specific inhibition of oncogenic pathways did not provide a significant survival benefit in advanced progressive thyroid cancer that is resistant to radioactive iodine therapy. Accumulating evidence clearly shows that cellular energy metabolism, which is controlled by oncogenes and other tumor-related factors, is a critical factor determining the clinical phenotypes of cancer. However, the role and nature of energy metabolism in thyroid cancer remain unclear. In this article, we discuss the role of cellular energy metabolism, particularly mitochondrial energy metabolism, in thyroid cancer. Determining the molecular nature of metabolic remodeling in thyroid cancer may provide new biomarkers and therapeutic targets that may be useful in the management of refractory thyroid cancers.

Citations

Citations to this article as recorded by  
  • Exploring the clinical utility of DPP-IV and SGLT2 inhibitors in papillary thyroid cancer: a literature review
    Angelika Buczyńska, Maria Kościuszko, Adam Jacek Krętowski, Anna Popławska-Kita
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Liquid Biopsy as a Method for Minimally Invasive Diagnosis of Thyroid Cancer
    Tagir I. Rakhmatullin, Mark Jain, Larisa M. Samokhodskaya, Vladimir A. Zhivotov
    Journal of Clinical Practice.2023; 14(3): 69.     CrossRef
  • Development of Metabolic Synthetic Lethality and Its Implications for Thyroid Cancer
    Sang-Hyeon Ju, Seong Eun Lee, Yea Eun Kang, Minho Shong
    Endocrinology and Metabolism.2022; 37(1): 53.     CrossRef
  • Monensin Inhibits Anaplastic Thyroid Cancer via Disrupting Mitochondrial Respiration and AMPK/mTOR Signaling
    Yanli Li, Qianshu Sun, Sisi Chen, Xiongjie Yu, Hongxia Jing
    Anti-Cancer Agents in Medicinal Chemistry.2022; 22(14): 2539.     CrossRef
  • Growth Differentiation Factor 15 is a Cancer Cell-Induced Mitokine That Primes Thyroid Cancer Cells for Invasiveness
    Yea Eun Kang, Jin Man Kim, Mi Ae Lim, Seong Eun Lee, Shinae Yi, Jung Tae Kim, Chan Oh, Lihua Liu, Yanli Jin, Seung-Nam Jung, Ho-Ryun Won, Jae Won Chang, Jeong Ho Lee, Hyun Jung Kim, Hyun Yong Koh, Sangmi Jun, Sun Wook Cho, Minho Shong, Bon Seok Koo
    Thyroid.2021; 31(5): 772.     CrossRef
  • Clinical Significance of the D-Loop Gene Mutation in Mitochondrial DNA in Laryngeal Cancer
    Lei Wang, He-Xiang Cheng, Yan-Hui Zhou, Min Ma
    OncoTargets and Therapy.2021; Volume 14: 3461.     CrossRef
  • Transcriptomic and Genetic Associations between Alzheimer’s Disease, Parkinson’s Disease, and Cancer
    Jaume Forés-Martos, Cesar Boullosa, David Rodrigo-Domínguez, Jon Sánchez-Valle, Beatriz Suay-García, Joan Climent, Antonio Falcó, Alfonso Valencia, Joan Anton Puig-Butillé, Susana Puig, Rafael Tabarés-Seisdedos
    Cancers.2021; 13(12): 2990.     CrossRef
  • KLF5 influences cell biological function and chemotherapy sensitivity through the JNK signaling pathway in anaplastic thyroid carcinoma
    Zheng Wang, Xinguang Qiu, Hao Zhang, Weihan Li
    Journal of Biochemical and Molecular Toxicology.2020;[Epub]     CrossRef
  • Metabolic reprogramming related to whole-chromosome instability in models for Hürthle cell carcinoma
    Ruben D. Addie, Sarantos Kostidis, Willem E. Corver, Jan Oosting, Sepideh Aminzadeh-Gohari, René G. Feichtinger, Barbara Kofler, Mehtap Derya Aydemirli, Martin Giera, Hans Morreau
    Scientific Reports.2020;[Epub]     CrossRef
  • Inhibition of mitochondrial respiration by tigecycline selectively targets thyroid carcinoma and increases chemosensitivity
    Yuehua Wang, Fei Xie, Dejie Chen, Ling Wang
    Clinical and Experimental Pharmacology and Physiology.2019; 46(10): 890.     CrossRef
  • Investigating Therapeutic Effects of Retinoic Acid on Thyroid Cancer via Protein-Protein Interaction Network Analysis
    Majid Rezaei-Tavirani, Mostafa Rezaei-Tavirani, Mona Zamanian Azodi
    International Journal of Cancer Management.2019;[Epub]     CrossRef
  • CASE REPORT: An Extensively Necrotic Hürthle-Cell Carcinoma Mimicked a Thyroid Abscess
    Sanders H. Lin, Shih-Ming Huang, Su-Lin Peng
    Clinical Thyroidology.2018; 30(11): 529.     CrossRef
  • Atovaquone enhances doxorubicin’s efficacy via inhibiting mitochondrial respiration and STAT3 in aggressive thyroid cancer
    Zhuo Lv, Xintong Yan, Liying Lu, Chun Su, Yin He
    Journal of Bioenergetics and Biomembranes.2018; 50(4): 263.     CrossRef
  • Identification of novel biomarker and therapeutic target candidates for diagnosis and treatment of follicular carcinoma
    Xianyin Lai, Christopher B. Umbricht, Kurt Fisher, Justin Bishop, Qiuying Shi, Shaoxiong Chen
    Journal of Proteomics.2017; 166: 59.     CrossRef
  • Pathological processes and therapeutic advances in radioiodide refractory thyroid cancer
    Marika H Tesselaar, Johannes W Smit, James Nagarajah, Romana T Netea-Maier, Theo S Plantinga
    Journal of Molecular Endocrinology.2017; 59(4): R141.     CrossRef
  • Integrated microRNA, gene expression and transcription factors signature in papillary thyroid cancer with lymph node metastasis
    Nurul-Syakima Ab Mutalib, Sri Noraima Othman, Azliana Mohamad Yusof, Shahrun Niza Abdullah Suhaimi, Rohaizak Muhammad, Rahman Jamal
    PeerJ.2016; 4: e2119.     CrossRef
Close layer
Original Article
Obesity and Metabolism
Mitochondrial Complexes I and II Are More Susceptible to Autophagy Deficiency in Mouse β-Cells
Min Joo Kim, Ok Kyong Choi, Kyung Sil Chae, Min Kyeong Kim, Jung Hee Kim, Masaaki Komatsu, Keiji Tanaka, Hakmo Lee, Sung Soo Chung, Soo Heon Kwak, Young Min Cho, Kyong Soo Park, Hye Seung Jung
Endocrinol Metab. 2015;30(1):65-70.   Published online March 27, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.1.65
  • 3,939 View
  • 40 Download
  • 4 Web of Science
  • 3 Crossref
AbstractAbstract PDFPubReader   
Background

Damaged mitochondria are removed by autophagy. Therefore, impairment of autophagy induces the accumulation of damaged mitochondria and mitochondrial dysfunction in most mammalian cells. Here, we investigated mitochondrial function and the expression of mitochondrial complexes in autophagy-related 7 (Atg7)-deficient β-cells.

Methods

To evaluate the effect of autophagy deficiency on mitochondrial function in pancreatic β-cells, we isolated islets from Atg7F/F:RIP-Cre+ mice and wild-type littermates. Oxygen consumption rate and intracellular adenosine 5'-triphosphate (ATP) content were measured. The expression of mitochondrial complex genes in Atg7-deficient islets and in β-TC6 cells transfected with siAtg7 was measured by quantitative real-time polymerase chain reaction.

Results

Baseline oxygen consumption rate of Atg7-deficient islets was significantly lower than that of control islets (P<0.05). Intracellular ATP content of Atg7-deficient islets during glucose stimulation was also significantly lower than that of control islets (P<0.05). By Oxygraph-2k analysis, mitochondrial respiration in Atg7-deficient islets was significantly decreased overall, although state 3 respiration and responses to antimycin A were unaffected. The mRNA levels of mitochondrial complexes I, II, III, and V in Atg7-deficient islets were significantly lower than in control islets (P<0.05). Down-regulation of Atg7 in β-TC6 cells also reduced the expression of complexes I and II, with marginal significance (P<0.1).

Conclusion

Impairment of autophagy in pancreatic β-cells suppressed the expression of some mitochondrial respiratory complexes, and may contribute to mitochondrial dysfunction. Among the complexes, I and II seem to be most vulnerable to autophagy deficiency.

Citations

Citations to this article as recorded by  
  • Proteomic pathways to metabolic disease and type 2 diabetes in the pancreatic islet
    Belinda Yau, Sheyda Naghiloo, Alexis Diaz-Vegas, Austin V. Carr, Julian Van Gerwen, Elise J. Needham, Dillon Jevon, Sing-Young Chen, Kyle L. Hoehn, Amanda E. Brandon, Laurence Macia, Gregory J. Cooney, Michael R. Shortreed, Lloyd M. Smith, Mark P. Keller,
    iScience.2021; 24(10): 103099.     CrossRef
  • Natural compound oblongifolin C inhibits autophagic flux, and induces apoptosis and mitochondrial dysfunction in human cholangiocarcinoma QBC939 cells
    Aiqing Zhang, Wei He, Huimin Shi, Xiaodan Huang, Guozhong Ji
    Molecular Medicine Reports.2016; 14(4): 3179.     CrossRef
  • Autophagy deficiency in β cells blunts incretin-induced suppression of glucagon release from α cells
    Min Joo Kim, Ok Kyong Choi, Kyung Sil Chae, Hakmo Lee, Sung Soo Chung, Dong-Sik Ham, Ji-Won Kim, Kun-Ho Yoon, Kyong Soo Park, Hye Seung Jung
    Islets.2015; 7(5): e1129096.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism